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SUMMARY  
 
Background 
Atrial fibrillation (AF) is the most common clinically relevant cardiac arrhythmia. AF is 
associated with reduced functional capacity and other symptoms, drug use, poor 
subjective health, increased risk of ischemic stroke and increased mortality.  
Physical activity (PA) reduces the risk of cardiovascular diseases and has multiple 
beneficial health effects, but male endurance athletes seem to have an increased risk of 
AF. Few studies, however, have investigated the association between prolonged 
endurance exercise and the risk of AF, and this association has not been studied in 
women previously. The number of individuals aged >40 years that engage in endurance 
sports events is increasing, but few studies have investigated the association between 
endurance sport practice and risk of AF in veteran athletes. Furthermore, AF and its 
consequences have been just sporadically described in veteran athletes previously.  
The main aims of this thesis were 1) to investigate endurance sport practice as a risk 
factor for AF in veteran athletes (paper I), 2) to investigate the association between 
prolonged regular endurance exercise and risk of AF in men (paper II), 3) to investigate 
the association between prolonged regular endurance exercise and risk of AF in women 
(paper III), and 4) to characterize AF and investigate PA, endurance exercise, symptoms, 
drug use and subjective health in veteran athletes with AF (paper IV). 
Methods 
Paper I is based on the Birkebeiner Ageing Study. In this cross-sectional study, 509 out 
of 607 invited men (84%) aged ≥65 years who took part in the 54-kilometer Birkebeiner 
cross-country ski race in 2009 or 2010 participated. These veteran athletes were 
compared to 1768 out of 2757 invited men aged ≥65 years (68%) participating in a 
population-based health study. The main outcome AF was self-reported by 
questionnaires. The main exposure was endurance sport practice, defined as 
participating in the Birkebeiner race. We calculated adjusted risk differences (aRDs) for 
AF with 95% confidence intervals (CIs) using a linear regression model. 
In the papers II and III, we investigated the association between prolonged regular 
endurance exercise and the risk of AF in men and women, respectively. These papers are 
based on a second study, the Birkebeiner Atrial Fibrillation Study. The study population 
of this retrospective cohort study comprised two distinct cohorts: 1) Veteran athletes 
aged ≥53 years who had participated in the Birkebeiner race in 1999, and 2) 
participants in the same group in a population-based health study. In total, 5390 out of 
7500 invited men and women (72%) took part in the Birkebeiner Atrial Fibrillation 
Study. In the study of men (paper II), the main outcome was AF and atrial flutter (AFL) 
confirmed by electrocardiograms (ECGs) in a review of medical records. Due to the low 
number of confirmed AF cases among female participants, self-reported AF was the 
main outcome in the analysis of women (paper III). The main exposure, years of regular 
endurance exercise was self-reported by questionnaires. Regular endurance exercise 
was defined as exercise for at least 30 minutes ≥3 times per week with the purpose of 
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increasing physical endurance capacity. Adjusted odds ratios (aORs) for AF with CIs 
were calculated using weighted logistic regression models. 
Also paper IV is based on the Birkebeiner Atrial Fibrillation Study. In this study, we 
characterized AF in detail among 140 veteran skiers and 118 individuals from the 
general population with confirmed AF. Furthermore, we investigated engagement in PA 
and endurance exercise after the onset of AF, palpitations, functional capacity, drug-use 
and subjective health in veteran athletes with AF and in the general AF population.  
Results 
The prevalence of self-reported AF in the Birkebeiner Ageing Study was 13.2% in the 
veteran athletes and 11.6% in the men from the general population. After multivariable 
adjustment for age, height, body mass index (BMI), coronary heart disease (CHD), 
hypertension, diabetes mellitus, smoking, alcohol consumption, leisure-time PA during 
the past year and education, endurance sport practice was associated with an added risk 
of AF of 6 percent points (pp) (aRD 6.0 (CI 0.8-11.1)), corresponding to an aOR of 1.90 
(CI 1.14-3.18).  
In the Birkebeiner Atrial Fibrillation Study, the prevalence of self-reported AF was 
12.5% among the male veteran athletes. After multivariable adjustment for age, height, 
concomitant heart disease, hypertension, diabetes mellitus and cohort affiliation, years 
of regular endurance exercise was associated with a gradually increased risk of both AF 
and AFL. Per 10 years of exercise, the aOR was 1.16 (CI 1.06-1.29) for AF and 1.42 (CI 
1.20-1.69) for AFL. In stratified analyses, the associations were significant both in the 
veteran athletes and in the men from the general population. Men who had exercised 
regularly for ≥40 years had an aOR for AF of 1.94 (CI 1.19-3.14)) compared to men who 
had never exercised regularly. 
The prevalence of self-reported AF among female veteran skiers was 8%. After 
multivariable adjustment for age, BMI, concomitant heart disease, hypertension, 
diabetes mellitus and cohort affiliation, women who had exercised regularly for ≥40 
years had an increased risk of AF of borderline significance (aOR 2.18 (CI 0.94-5.06)) 
compared to women who had never exercised regularly. 
Among veteran athletes with AF, 52% had paroxysmal, 23% had persistent and 24% had 
permanent AF. AF was associated with poor subjective health, but 89% of the veteran 
athletes were physically active and 64% engaged in regular endurance exercise after the 
onset of AF. While 59% had experienced palpitations during the past year, 32% reported 
reduced functional capacity. Two out of three with AF and an estimated CHA2DS2-VASc 
score ≥2 used oral anticoagulants (OACs). 
Conclusions 
In conclusion, 1) endurance sport practice seemed to be a risk factor for AF in men aged 
≥65 years, 2) years of regular endurance exercise was associated with a gradually 
increased risk of both AF and AFL in men, 3) our study indicated that prolonged 
endurance exercise might be associated with AF also in women, and 4) AF was 
associated with poor subjective health, but the vast majority of veteran athletes engaged 
in regular PA and endurance exercise also after the onset of AF.  
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NORSK SAMMENDRAG 
 
Innledning 
Atrieflimmer (AF) er den vanligste hjerterytmeforstyrrelsen som har klinisk betydning. 
AF er forbundet med redusert fysisk yteevne og andre symptomer, medisinbruk, dårlig 
selvopplevd helse, økt risiko for hjerneslag og økt dødelighet. 
Fysisk aktivitet (FA) reduserer risikoen for hjerte- og karsykdom og er forbundet med 
en rekke gunstige helseeffekter, men mannlige idrettsutøvere i utholdenhetsidretter ser 
ut til å ha en økt risiko for AF. Få studier har undersøkt sammenhengen mellom 
langvarig utholdenhetstrening og risiko for AF og tidligere studier har ikke funnet noen 
sammenheng mellom deltakelse i utholdenhetsidrett og risiko for AF blant kvinner. 
Stadig flere personer >40 år deltar i Birkebeinerrennet, maratonløp og lignende 
arrangementer, men FA og trening, symptomer, medisinbruk og selvopplevd helse blant 
eldre birkebeinere med AF har ikke blitt kartlagt tidligere.   
Hensikten med studiene i denne avhandlingen var 1) å undersøke deltakelse i 
utholdenhetskonkurranser som risikofaktor for AF blant eldre birkebeinere(artikkel I), 
2) å undersøke sammenhengen mellom langvarig regelmessig utholdenhetstrening og 
risiko for AF blant menn (artikkel II), 3) å undersøke sammenhengen mellom langvarig 
regelmessig utholdenhetstrening og risiko for AF blant kvinner (artikkel III), og 4) å 
beskrive AF og undersøke deltakelse i FA og utholdenhetstrening, symptomer, 
medisinbruk og selvopplevd helse blant eldre birkebeinere (personer ≥53 år som 
tidligere hadde deltatt i Birkebeinerennet (artikkel IV).  
Metoder 
Artikkel 1 er basert på Birkebeiner Aldringsstudien. Total 509 av 607 inviterte menn 
(84%) ≥65 år som var med i Birkebeinerrennet i 2009 eller 2010, deltok i denne 
tverrsnittsstudien. Birkebeinerne ble sammenlignet med 1768 av 2757 inviterte menn 
≥65 år (68%) som hadde deltatt i en helseundersøkelsen i Tromsø (Tromsø-
undersøkelsen). Studiens endepunkt var selv-rapportert AF og eksponeringen var 
deltakelse i Birkebeinerrennet. Justerte risikodifferanser (aRDs) med 95% 
konfidensintervaller (KIs) ble beregnet med en lineær regresjonsmodell.  
I artikkel II undersøkte vi sammenhengen mellom langvarig regelmessig 
utholdenhetstrening og risiko for AF blant menn, og i artikkel III ble den samme 
sammenhengen undersøkt blant kvinner. Begge artiklene er basert på Birkebeiner 
Atrieflimmer Studien. Studiepopulasjonen i denne retrospektive kohortstudien er 
sammensatt av to uavhengige kohorter: 1) Menn og kvinner ≥53 år som deltok i 
Birkebeinerrennet i 1999, og 2) deltakere i en helseundersøkelse i Oslo (Oslo-
undersøkelsen). Til sammen 5390 av de 7500 inviterte (72%) fra de to kohortene deltok 
i Birkebeiner Atrieflimmer Studien. AF og atrieflutter (AFL) bekreftet med 
elektrokardiogram under en gjennomgang av sykehusjournaler var hovedendepunktene 
i artikkel II. Fordi antallet kvinner med tilgjengelig journal var lavt, ble selv-rapportert 
AF valgt som endepunkt i studien av kvinner (artikkel III). Eksponeringen var selv-
rapportert antall år med regelmessig utholdenhetstrening. Regelmessig 
utholdenhetstrening ble definert som utholdenhetstrening av minst 30 minutters 
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varighet minst tre ganger i uken med mål om å forbedre utholdenhet.  Justerte odds 
ratioer (aORs) med KIs ble beregnet med vektet logistisk regresjon.  
Også artikkel IV er basert på Birkebeiner Atrieflimmer Studien. I denne artikkelen 
beskrev vi AF blant 140 birkebeinere og 118 personer fra den generelle befolkningen 
(Oslo-undersøkelsen) med bekreftet AF. Vi undersøkte også deltakelse i PA og 
utholdenhetstrening blant personer med AF, samt symptomer som hjertebank og 
redusert fysisk yteevne, medisinbruk og selvopplevd helse. 
Resultater 
Forekomsten av AF i Birkebeiner Aldringsstudien var 13.2% blant birkebeinerne og 
11.6% i utvalget fra Tromsø-undersøkelsen. Etter justering for alder, kroppshøyde, 
kroppsmasseindeks (KMI), koronar hjertesykdom, høyt blodtrykk, diabetes mellitus, 
røyking, alkoholvaner, FA siste år og utdanningsnivå, var deltakelse i Birkebeinerrennet 
forbundet med et tillegg i risiko for AF på 6 prosentpoeng (pp) (aRD 6.0 (KI 0.8-11.1)). 
Dette tilsvarer en aOR på 1.90 (KI 1.14-3.18). 
I Birkebeiner Atrieflimmer Studien var forekomsten av selv-rapportert AF blant de 
mannlige birkebeinerne 12.5%. Etter justering for alder, kroppshøyde, annen 
hjertesykdom, høyt blodtrykk, diabetes mellitus og kohort, var antall år med regelmessig 
utholdenhetstrening forbundet med en gradert økt risiko for både AF og AFL. Per tiår 
med trening var aOR 1.16 (KI 1.06-1.29) for AF og 1.42 (KI 1.20-1.69) for AFL. I 
stratifiserte analyser var sammenhengen signifikant både blant birkebeinerne og i 
utvalget fra Oslo-undersøkelsen. Menn som hadde trent regelmessig i ≥40 år hadde en 
aOR for AF på 1.94 (KI 1.19-3.14)) sammenlignet med menn som aldri hadde trent 
regelmessig. 
Forekomsten av selv-rapportert AF blant de kvinnelige birkebeinerne var 8%. Etter 
justering for alder, KMI, annen hjertesykdom, høyt blodtrykk, diabetes mellitus og 
kohort, hadde kvinner som hadde trent regelmessig i ≥40 år en grensesignifikant 
forhøyet risiko for AF (aOR 2.18 (KI 0.94-5.06)) sammenlignet med kvinner som aldri 
hadde trent regelmessig. 
Blant birkebeinerne med AF hadde 52% paroksysmal AF (anfall som går over av seg 
selv), 23% hadde persistent AF (anfall som går over etter behandling) og 24% 
permanent AF. AF var forbundet med dårlig selvopplevd helse, men 89% av 
birkebeinerne var fysisk aktive og 64% drev fortsatt med regelmessig 
utholdenhetstrening etter at de hadde fått AF. Mens 59% rapporterte å ha hatt 
hjertebank siste år, hadde 32% opplevd redusert fysisk yteevne. To av tre med AF og en 
estimert CHA2DS2-VASc ≥2 brukte orale antikoagulantia.  
Konklusjoner  
1) Deltakelse i Birkebeinerrennet så ut til å være en risikofaktor for AF blant menn ≥65 
år, 2) antall år med regelmessig utholdenhetstrening var assosiert med en gradert økt 
risiko for både AF og AFL hos menn, 3) vår studie indikerte at langvarig 
utholdenhetstrening kan være forbundet med en økt risiko for AF også blant kvinner, og 
4) AF var forbundet med dårlig selvopplevd helse, men majoriteten av birkebeinerne var 
regelmessig fysisk aktive og deltok i utholdenhetstrening også etter at de hadde fått AF. 
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1 INTRODUCTION 
1.1 Physical activity and endurance exercise  
1.1.1 Definitions 
In terms of health-related research PA is defined as any bodily movement produced by 
skeletal muscles that results in energy expenditure [1]. The energy expenditure varies 
continuously from low to high and the lowest energy expenditure is seen during 
sedentary activities that involve sitting [2]. In research, PA is often categorized into 
occupational or leisure-time PA. Leisure-time PA covers households tasks like for 
example gardening, and recreational activities like cycling, walking and even regular 
exercise, and has traditionally been divided into 4 subcategories: Sedentary, light, 
moderate and high PA [3].  
While PA covers bodily movement at any level, exercise is defined as planned, structured 
and repetitive bodily movement with the purpose to improve or maintain physical 
fitness [1]. The goal of endurance exercise is the improvement of physical capacity by 
increasing the maximum oxygen consumption. Endurance sports like cross-country 
skiing are characterized by a high dynamic component, defined in terms of a high 
achieved percent of maximal oxygen consumption and a high cardiac output during 
activity [4]. In this thesis, regular endurance exercise is defined as exercise for ≥30 
minutes at least three times per week with the purpose of increasing physical endurance 
capacity. Prolonged endurance exercise is used to describe such exercise that has been 
continued for many years.  
Over the last decades, there has been an increased participation in endurance sports 
events like marathons, triathlons and long-distance cross-country ski races [5, 6]. In this 
thesis the term endurance sport practice is used to describe participation in such 
endurance sports events. 
There term athlete is widely used, but there is a lack of a clear-cut and uniform 
definition in previous studies [7]. Former or veteran athletes have previously been used 
to describe former top-level athletes aged 46-72 years [8, 9]. In this thesis we use the 
term veteran athletes to describe individuals who have participated in a long-distance 
cross-country ski race when aged ≥40 years.  
1.1.2 Physical activity, endurance exercise and health outcomes  
Already more than 2,000 years ago Hippocrates stated that “…the sick will of course 
profit to a great extent from gymnastics with regard to the restoration of their health, 
and the healthy will profit with regard to its maintenance, and those who exercise will 
profit with regard to the maintenance of their well-being and a lot more’’ [10].  
After the second world war, Jeremy N. Morris and his colleagues were the first to 
investigate the association between physical inactivity and risk of cardiovascular disease 
and death with modern epidemiological methods [11]. In a study conducted among 
>31 000 male employees of the London Transport Executive, Morris et al, demonstrated 
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that the inactive drivers of the London buses had about the double age-adjusted rate of 
the conductors who ran up and down the stairs of the buses to sell tickets, of both fatal 
and non-fatal CHD. Since, knowledge regarding associations between PA and various 
health outcomes has been added and today PA and exercise are recognized as 
cornerstones of the primary prevention of many diseases and conditions. Reduced 
mortality is the best documented among the many beneficial health effects of PA [12-
17], but also a reduced risk of cardiovascular diseases by regular PA is well established 
[18-24]. Furthermore, PA reduces the risk of stroke and cardiovascular risk factors like 
hypertension, diabetes mellitus and obesity [25-33], and a reduced risk of cancer by PA 
has been demonstrated [34-38].  
Because the prevalence of risk factors increases with increasing age, the potential 
benefits of PA and exercise might be highest in the oldest age groups. In a recent 
Norwegian study, the relative importance of PA as health promoting factor increased 
with increasing age, when compared to other cardiovascular risk factors [39]. Improved 
cognitive functions and reduced risk of dementia, reduced risk of depression, increased 
muscle strength and volume, improved mobility, increased bone density, and reduced 
risk of falls and fractures are among other benefits of PA observed in studies of old 
individuals [40, 41].  
Finally, although rest was recommended for patients with established CHD for decades, 
exercise is today the most important component of cardiac rehabilitation and secondary 
prevention of many diseases [42, 43].  
It seems to be an inverse dose-response relationship between PA and health outcomes: 
Increased levels of PA are associated with lower mortality and morbidity [44]. The 
largest improvement might be achieved by moving from inactive to active, while less 
benefit could be expected by increasing the activity level from moderate to high [45, 46]. 
However, also endurance exercise is associated with reduced mortality [47-50]. In a 
recently published study among >44,000 men in the United States, increasing amounts 
of high PA remained inversely associated with the risk of cardiovascular and other 
diseases, even among the men in the highest categories of exercise [51].  Also elite 
athletes have lower mortality rates than the general population [52]. On the other hand, 
in a cohort study of Dutch male non-elite participants in a long-distance speed skating 
event, the mortality was lower among those who participated in the recreational tour 
compared to those who competed in the race [50]. Recently, a Danish study suggested a 
U-shaped association between dose of jogging and mortality [53]. Thus, the optimal dose
of exercise in terms of health promotion is controversial, and there is a need for studies
that include individuals exposed to various levels of exercise [46, 54].
1.1.3 Adverse effects of endurance exercise and sport practice 
In general, exercise has few harmful side-effects. Some activities like alpine skiing, bike 
cycling, boxing and other contact sports are related to an increased risk of traumatic 
injuries, and running frequently cause musculoskeletal overuse-injuries [55]. But most 
sports injuries are minor and have relatively little impact on the general health 
condition. It is well known that endurance sport practice might induce life-threatening 
ventricular arrhythmias and cause sudden cardiac death (SCD). In most cases of SDC in 
athletes, however, there is an underlying cardiovascular abnormality [56-58]. The 
incidence of SDC in athletes might be expected to increase, as the number of older and 
17 
less fit individuals that engage in endurance sport events is increaseing [5, 6, 59]. In a 
Swedish study, cross-country skiers participating in the 90-kilometer Vasaloppet had an 
increased risk of acute mortality during the race, but the authors of the paper concluded 
that this risk was by far outweighed by the long-term protective effects on mortality of 
PA and exercise [49].  
1.2 Atrial fibrillation 
1.2.1 Definition, classification natural course 
AF was first described in humans by Einthoven in 1906 [60]. AF is the most common 
sustained cardiac arrhythmia and characterized by absolutely irregular RR intervals in 
the ECG. The precise underlying mechanisms are still under debate [61], but the 
arrhythmia is mainly initiated by triggers located in the pulmonary veins and 
maintained due to micro-circuits of electrical waves, usually referred to as micro-re-
entries or rotors [62]. AF is usually classified into three or five subtypes. In clinical 
practice in Norway three subtypes are commonly used:  
1) Paroxysmal - self-terminating AF, usually within 48 hours.
2) Persistent - AF episodes that last longer than seven days or require termination
by cardioversion with drugs or by direct current cardioversion.
3) Permanent – AF that is present permanently.
In addition, the 2012 focused update of the European Society of Cardiology (ESC) 
guidelines recommend to use two other subtypes [63]:    
4) First-time diagnosed AF, and
5) Long-lasting persistent AF that has lasted for more than one year.
The natural course of the arrhythmia is a progression from short and rare episodes to 
longer lasting and more frequent attacks. AF paroxysms vary over time and between 
individuals, both in terms of frequency, duration and symptoms. Only 2-3% of all AF 
patients remain with paroxysmal AF over time [64], and AF typically develops into a 
more permanent arrhythmia with increasing age. Thus, the proportions of the AF 
subtypes vary dependent on the studied population. In a prevalence study among 75-
years old Norwegians, 11% of the individuals with AF had first-time diagnosed AF, 36% 
had paroxysmal, 1% had persistent and 52% had permanent AF [65]. 
1.2.2 Epidemiology 
The overall prevalence of AF in the general western population is 1-2 %, but the 
prevalence increases with increasing age [66]. The prevalence is less than 0.5% before 
the age of 50 years, but increases steeply from the age of around 65 to around 10% in 
individuals aged 75 years, and more than 15% in those aged over 80 years [67, 68]. 
Figure 1 shows the prevalence of AF by age group in men and women in three 
population-based studies conducted in Tromsø, Skellefteå (Northern Sweden) and 
Rotterdam. The prevalence was highest in the Tromsø study, were AF was self-reported 
(unpublished data from the Tromsø Study). Similar to CHD [69], AF seems to occur 5-10 
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years later in women than in men. The prevalence was higher in the Swedish study from 
2010 compared to the Rotterdam study conducted around 20 years earlier. Due to 
increased survival after acute coronary syndrome, increased prevalence of risk factors 
for AF like obesity and diabetes and the ageing population, the prevalence of AF might 
be increasing over time, with estimates indicating a doubled prevalence within the next 
50 years [66, 70]. 
There are no complete AF prevalence data available for the Norwegian population. Tveit, 
et al, found a prevalence of 10% in a population of 75-years old Norwegians , 6% in 
women and 15% in men [65]. In 2011, Tveit estimated that 73,500 Norwegians had AF 
and that the prevalence is likely to be doubled until 2040 [71]. 
Figure 1. Prevalence of atrial fibrillation by age group and gender in Tromsø (2007-08) 
(unpublished data from the Tromsø study), Skellefteå (Northern Sweden) (2010) and 
Rotterdam (1990-93), modified [67, 68].  
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1.2.3 Symptoms  
The most commonly reported symptom among AF patients is palpitations [72]. In this 
thesis palpitations are defined as sudden changes in the heart rate or heart rhythm that 
are perceived by the patient. Other commonly reported symptoms are dyspnea, chest 
pain, dizziness, fatigue, anxiety, exercise intolerance and reduced functional capacity 
[72]. In this thesis reduced functional capacity is defined as limitations in physical 
functions due to symptoms like dyspnea, chest pain or fatigue related to the heart 
disease, as measured by the New York Heart Association (NYHA) classification. 
Furthermore, AF is related to poor subjective health and drug use [73, 74]. In previous 
studies, patients with paroxysmal AF were more likely to be symptomatic than patients 
with permanent AF [74]. Symptoms in AF patients might be caused by the arrhythmia 
itself or by concomitant conditions. As heart failure, CHD, heart valve diseases and other 
co-morbidities are common in AF patients, the causes of symptoms are probably 
multifactorial in many individuals [72]. The symptom burden is therefore likely to vary 
dependent on the studied population.  
1.2.4 Consequences  
AF is associated with increased risk of all-cause mortality, stroke and heart failure [75].  
In the Framingham Study, AF was associated with an aOR of death of 1.5 (CI 1.2 – 1.8) 
[76], and among Swedish AF patients, the standardized mortality ratio was 1.6 (CI 1.4 – 
1.8) compared to the general population [77]. In this study, the increased mortality 
appeared to be related to concomitant cardiovascular risk factors, but in another 
Swedish study, AF was found to be an independent risk factor for mortality, even after 
adjustment for co-morbidity [78]. In another study, the relative risk (RR) for death in 
individuals with AF was higher in women than in men (RR 2.2 versus 1.5) [75].  
In a population of >186,000 AF patients with a mean age of 79.5 years and a high 
prevalence of co-morbid conditions, death was the most frequent major outcome within 
the first five years after the diagnosis of AF [79]. The cumulative incidence of death was 
19.5% after 1 year and 48.8% after 5 years. After 5 years of follow-up, 13.7% of the 
patients had a hospitalization or emergency department visit for heart failure, 7.1% 
developed stroke, 5.7% had a gastrointestinal bleeding and 3.9% had a myocardial 
infarction.  
The overall risk of stroke is around five times higher among AF patients compared to the 
general population [80]. While paroxysmal AF seems to carry the same risk as 
permanent AF [77], the risk of stroke depends upon age, sex and concomitant risk 
factors [81-83]. Cardiac failure or dysfunction, hypertension, age ≥75 years (≥65 years), 
diabetes mellitus, previous stroke, other vascular disease and female gender have been 
identified as important risk factors for stroke in AF patients and are implemented in the 
modified CHA2DS2-VASc-score, that has been recommended in the decision-making 
about OAC treatment in order to prevent stroke in AF patients [63, 84]. The increased 
risks of both death and stroke are reduced by OAC [63, 66, 77, 85], but the adherence to 
OAC treatment has been found unsatisfactory in previous studies [86-89]. 
1.2.5 Etiology and risk factors 
Although the understanding of the etiology of AF is still incomplete, a broad spectrum of 
risk factors has been associated with AF during the last decades. Recently, several 
papers divided these into conventional or validated risk factors that are well 
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documented, and less established, less validated, newer or emerging risk factors [90-92]. 
Risk factors for AF based on recent reviews are summarized in table 1. Endurance sport 
practice and endurance exercise are listed among the less established risk factors for AF.  
Historically, the term lone AF has been used to describe AF in younger individuals 
without any other cardiovascular disease or other detectable relevant co-morbidity. 
However, the long list of emerging risk factors has raised the questions whether lone AF 
does exist, and whether the term should be avoided or not [91]. 
Table 1. Established and less established risk factors for atrial fibrillation, based on 
recent reviewsa [90-92]. 
Established risk factors Less established risk factors 
Advancing age Obesity 
Male gender Body height 
Hypertension Obstructive sleep apnea syndrome 
Coronary heart disease Chronic obstructive pulmonary disease 
Valvular heart disease Chronic kidney disease 
Heart failure Subclinical hyperthyroidism 
Diabetes mellitus Excessive alcohol consumption 
Hyperthyroidism Smoking  
Genetic factors Coffee 
(Biomarkers of) inflammation (CRP, TNF-alfa, IL6) 
Biomarkers of hemodynamics stress (ANP, BNP) 
Biomarkers of cardiac damage (Troponin T) 
Prolonged endurance exercise 
Endurance sport practice 
Murmur 
Pre-clinical atherosclerosis 
Birth weight >4 kg 
Psychological determinants (stress, anger, hostility) 
Left atrial dilatation 
Left ventricular hypertrophy 
Diastolic dysfunction 
Atrial conduction delay (PR-interval) 
a The list is not necessarily exhaustive. 
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1.2.6 Atrial flutter 
AFL is an atrial arrhythmia closely related to AF. AFL is the second most common 
clinically relevant arrhythmia, but its prevalence is less than one tenth of that of AF [93]. 
Also AFL is strongly related to increasing age, most often occurs in relation to co-morbid 
conditions and is associated with the same long-term consequences as AF [94]. As in AF, 
AFL is often characterized by an increased heart rate, but unlike AF, the heart rate is 
regular. 
1.3 Endurance exercise, sport practice and risk of atrial fibrillation 
1.3.1 Previous studies of Norwegian cross-country skiers 
Already in 1978 Lie and Erikssen showed that ECG abnormalities were frequent in male 
Norwegian cross-country skiers participating in the Birkebeiner race [95]. After five 
years follow-up, they concluded that the abnormalities probably were explained by 
physiological adaption to exercise, and that exercise seemed to protect against CHD [96]. 
In the BirkOpp-study, Grimsmo, et al, studied morbidity and mortality in a 28-30-years 
follow-up of 78 of the same skiers. The skiers were aged 54-92 years at follow-up and 
had a high overall prevalence of AF of 16.7%. The prevalence of lone AF was 12.8 % [97]. 
Echocardiographic evaluation revealed that a high proportion of the skiers had enlarged 
left atrium dimensions. Long PQ time, bradycardia and left atrial enlargement were 
predictors for AF in this study [98]. The mortality was lower in the skiers compared to 
the general population [99]. Sivertsen, et al, studied 24 cross-country skiers who had 
been part of the Norwegian national team 25 years after their active competing period 
[100]. The main result of this study was that the athletes had maintained their physical 
capacity well after concluding their careers. Two athletes developed paroxysmal AF 
during the follow-up. In another study, Bjørnstad, et al, followed 30 Norwegian elite 
endurance athletes for 15 years [101]. All 30 had ended their professional careers, but 
were still engaged in recreational activities. There were no cases of AF, AFL or other 
clinical events during the follow-up.  
1.3.2 Previous studies of atrial fibrillation in athletes 
In 1998, Karjalainen, et al, were the first to describe an association between endurance 
sport practice and AF [8]. Finnish male elite orientation runners aged 35 to 59 years at 
inclusion were compared with healthy men of the same age and followed-up for ten 
years. Individuals with incident cardiovascular diseases during the follow-up were 
excluded. The prevalence of lone AF was five-fold higher in the orientation runners than 
in the control group (OR 5.5 (CI 1.3 – 24.4)). The main strengths of this study were the 
long follow-up and that also mortality and cardiovascular diseases were recorded. The 
study was limited by a low AF incidence and a twice as high number of drop-outs in the 
control group compared to the athletes. Interestingly, when analyzing the data without 
excluding those with incident cardiovascular diseases others than AF, there were no 
significant difference in the AF incidence between the groups [102]. Since 1998, atrial 
arrhythmias have been studied in other populations of athletes. Studies published until 
2012 are summarized in table 2.  
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Table 2. Studies of atrial fibrillation in athletes published until 2012. 
Study Study design and 
population(s) 
AF cases Risk 
estimates 
Comments 
Sivertsen, 
1994 [100] 
Cohort study, 24 
Norwegian elite cross-
country skiers, 25 years 
follow-up, no control 
group 
2 - 1 death due to
myocardial
infarction.
Karjalainen, 
1998 [8] 
Cohort study, 262 
Finnish elite orientation 
runners vs. healthy 
recruits, 10 years follow-
up 
12 
athletes, 2 
controls 
Lone AF: 
OR 5.5, CI 
1.3 – 24.4 
Higher number of 
drop-outs in the 
control group. 
Molina, 2008 
[103] 
Retrospective cohort 
study, 252 Spanish non-
elite marathon runners 
vs. sedative controls 
9 runners, 
2 controls 
HR 8.8 (CI 
1.3-61.3) 
Shorter follow-up 
period in the control 
group (6 vs. 11 
years). 44% 
smokers.  
Baldesberger, 
2008 [9] 
Retrospective cohort 
study, 62 Italian former 
professional cyclists vs. 
golf players, mean 
follow-up 38 years 
2  AF, 4 
AFL, none 
in 
controls 
- 71% admitted use
of doping. High
prevalence of CHD
and hypertension
Bjørnstad, 
2009 [101] 
Cohort study, 30 
Norwegian elite 
endurance athletes, no 
control group 
None - 
Grimsmo, 
2010 [97] 
Cohort study, 78 
Norwegian veteran 
cross-country skiers, 28-
30 years follow-up, no 
control group 
13 
(16.7%) 
- Prevalence of lone
AF 12.8%.
Pellicia, 2010 
[104] 
Cohort study, young 
Italian elite athletes, 
mean follow-up 8.6 
years, no control group 
None - Mean age 22 at
inclusion.
Van Buuren, 
2012 [105] 
Cross-sectional study, 33 
former top-level German 
handball players 
10 - Selection of athletes
with symptoms.
AF = Atrial fibrillation. AFL = Atrial flutter. CHD = Coronary heart disease. OR = Odds ratio. 
HR = Hazard ratio. 
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A common limitation of all these studies is the low number of AF cases. Another 
important limitation of many studies is the inadequate controlling for confounding 
factors. Despite a high prevalence of smokers among the Spanish marathon runners, 
only age and hypertension were included in the regression model [103]. Among the 
Italian cyclist, 44 out of 62 reported use of amphetamine or anabolic steroids [9]. The 
prevalence of AF is very low in young populations, and this is the most likely explanation 
for the negative results of the studies conducted in young Italian and Norwegian elite 
athletes [100, 104].  
1.3.3 Previous studies of the association between endurance exercise and 
the risk of atrial fibrillation 
Until 2012, one study had prospectively investigated the risk of AF by endurance 
exercise in a larger population. In the Physicians Health Study, 16,921 healthy male 
doctors aged 40-84 years were followed for 12 years [106]. Both exercise and AF were 
self-reported by questionnaires and 1661 men reported AF during the follow-up. A 
modestly increased risk for AF was found among the most active physicians who 
reported five to seven weekly hours of exercise (aRR 1.20 (CI 1.02 – 1.41)) In subgroup 
analyses, the AF risk was increased only in men aged <50 years who exercised five to 
seven days per week, and jogging was the only type of activity associated with AF.  The 
self-reporting of both the exposure and the outcome is the main limitation of this study. 
Furthermore, its generalizability is uncertain, because healthy physicians represent a 
selected population that might report both exercise and health outcomes differently 
from other populations.  
A group of sports cardiologists in Barcelona has studied sport practice among patients 
with lone AF attending their outpatient arrhythmia clinic. Among 1160 patients 
consecutively referred to this clinic, 51 men aged ≤65 years with lone AF were 
identified. 63% of the men with lone AF were sportsmen, compared to 15% in the 
general Catalonian population [107]. The same 51 men were included in a case-control 
study and compared to 109 controls from the general population. In this analysis, 
current sport practice combined with >1500 lifetime hours of self-reported exercise was 
associated with an OR for lone AF of 2.87 (CI 1.20-6.91). The authors suggested a 
threshold of 1500  hours of exercise that must be exceeded to facilitate AF [108]. In a 
third study, the Barcelona group demonstrated that PA, body height and left atrial size 
predicted lone AF [109]. This prospective case-control study of 107 patients with lone 
AF and 107 age- and sex-matched controls is interesting because both occupational PA, 
exercise and sports activity were assessed using a detailed questionnaire. All activities 
were categorized by intensity, but unfortunately and probably due to the small study 
size, both occupational PA and exercise were analyzed together in the multivariable 
regression analysis. This implies that occupational PA of high intensity was classified 
together with for instance competitive sport practice. The CIs were wide and 
overlapping between the categories of activity and the study was not able to 
demonstrate a dose-response relationship. A main limitation of all three studies might 
be that the outpatient arrhythmia clinic in Barcelona is known for its expertise in sports 
cardiology, which is likely to have introduced selection bias. 
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1.3.4 Meta-analysis and reviews 
In 2009, six case-control studies with a total of 655 athletes and 895 controls were 
included in a meta-analysis. The overall risk of AF was found to be significantly higher in 
the group of athletes than in the controls, with an OR for AF of 5.3 (CI 3.6 – 7.9) [110]. 
In 2012, we published a review article including both the meta-analysis and previous 
studies and concluded that the literature provided support for an increased risk of AF 
related to prolonged endurance exercise [111]. We discussed a number of important 
limitations: Two of the studies were based on the same patient material [107, 108], 
which might raise the suspicion of publication bias and an overestimation of the studied 
association. Most studies were likely to be affected by selection bias [8, 9, 103, 106, 108, 
109, 112], and some studies had a high risk of information bias, because the registration 
of the endpoint could be associated with the studied exposure [108, 109]. Finally, we 
highlighted the lack of controlling for confounding factors in some studies [8, 106, 113].  
Until 2012, several reviews were published, including largely the same studies as we 
did. Three reviews were published by Mont or others from the Barcelona group and 
concluded that growing evidence supports that prolonged endurance sport participation 
can cause cardiac structural changes and alterations in the autonomic system, which can 
facilitate atrial arrhythmias [114-116]. Sorokin, et al, concluded that evidence support 
that athletes are at increased risk of AF [117]. Turagam, et al, concluded that the 
prevalence of AF seemed to be higher in individuals involved in prolonged sport practice 
compared to general populations, but that evidence for a causal relation between sport 
practice and risk of AF was lacking [118]. On the other hand, Delise, et al, stated that 
there is no convincing data that sport itself may be the cause of AF and that a possible 
facilitating effect on AF is limited to vigorous endurance exercise [102]. Also Müller-
Riemenschneider, et al, concluded that the quality of evidence for an increased risk of AF 
by exercise was low, and that the risk is likely to be overestimated in most studies [119].  
1.3.5 Summary of previous studies 
Thus, the results of a few studies indicated a high prevalence of AF in athletes and an 
association between endurance sport practice and an increased risk of AF. With 
exception from the Physicians Health Study, which was conducted in a selected 
population of physicians, AF risk had only been studied in relatively small samples of 
men. Grimsmo, et al, had studied prolonged endurance sport practice among Norwegian 
veteran cross-country skiers, but without any control group. A common limitation of all 
previous studies was the lack of data on the association between exercise and AF in 
women.   
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2 AIMS OF THIS THESIS 
Based on the knowledge gap regarding the association between prolonged endurance 
sport practice and exercise and the risk of AF, the following main aims emerged for this 
thesis: 
I. To investigate endurance sport practice as a risk factor for AF in
veteran athletes (Paper I)
II. To investigate the association between prolonged regular endurance
exercise and risk of AF in men (Paper II)
III. To investigate the association between prolonged regular endurance
exercise and risk of AF in women (Paper III)
IV. To characterize AF and to investigate PA, endurance exercise,
symptoms, drug use and subjective health among veteran cross-
country skiers with AF (Paper IV)
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3 MATERIALS 
3.1 The Birkebeiner cross-country ski race 
The Birkebeiner race has been arranged almost annually since 1932 [120]. The race was 
initiated to honor the rescue of the 18-months old Norwegian Prince Haakon Haakonsen 
in 1206. After the death of King Haakon Sverreson, the rivaling fractions the Baglers and 
the Birkebeiners were fighting to gain control over Norway. With the aim of securing the 
throne, a group of Birkebeiners took care of king Haakon Sverresons son Haakon and 
protected him against the Baglers. On their way to Trondheim, the Birkebeiners chose 
the strenuous route across the mountains separating Gudbrandsdalen and Østerdalen, 
and the two best skiers among them carried the small prince. Haakon Haakonson grew 
to become the king who later united Norway after 1000 years of sivil war [121]. The 
name Birkebeiner referred to leggings of birch bark and was given by the Baglers to 
describe their enemies as poor and incapable. Since the Birkebeiners proved the the 
Baglers to be wrong, their name was later related to strength, endurance and pride. 
Today the word birkebeiner is commonly used to describe participants of the 
Birkebeiner race [121].   
Starting in Rena in Østerdalen and finishing in Lillehammer, the host city of the Olympic 
winter games of 1994, in Gudbrandsdalen, the course of the race is today 54 kilometers. 
With a total of about 1000 uphill altitude meters and often though weather conditions, 
the Birkebeiner race is among the world’s most challenging cross-country ski races. All 
participants have to carry a backpack of at least 3.5 kg, representing the weight of prince 
Haakon. While 147 men completed the very first race in 1932, today the race is among 
the most popular sport events in Norway, and around 15,000 men and women 
participate every year [120]. 
3.2 The Birkebeiner Ageing Study 
The study population of paper I is based upon 1) a cohort of male veteran cross-country 
skiers aged ≥65 who participated in the Birkebeiner Ageing Study, and 2) a cohort of 
men of the same age group participating in the population-based Tromsø Study. 
3.2.1 The Birkebeiner Ageing Study 
The Birkebeiner Ageing Study is a longitudinal study of veteran skiers participating in 
the Birkebeiner race. The main purpose of this study is to investigate associations 
between endurance sport practice and health in advanced age. Based on result lists 
provided by the race organizer, all 658 Norwegian skiers aged ≥65 years who completed 
the race in 2009 or 2010 and had a Norwegian postal address were invited to 
participate.  
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The inclusion of participants to the Birkebeiner Ageing Study took place in 2009 and 
2010. Altogether, 484 participants in Birkebeinerrennet 2009 received a postal 
questionnaire together with an invitation letter during October the same year. During 
December, 116 individuals who had not responded to this invitation received a postal 
reminder. Correspondingly, 174 participants in Birkebeinerrennet 2010 who were not 
already included in the study received the questionnaire and invitation letter during 
November 2010. In total, 90 individuals were reminded by e-mail during January 2011, 
using e-mail addresses provided by the Birkebeiner race organizer. This, however, was 
not successful, as many participants were registered with the e-mail address of family 
members or others. Therefore, 50 individuals were also reminded by a telephone call.  
Due to low number of female participants, only men were included in the analysis of this 
work.  All male responders, 509 out of 607 invited men (84%) aged 65 to 90 years, were 
included. In order to investigate endurance sport practice as a risk factor for AF, cross-
sectional baseline data from the Birkebeiner Ageing Study were compared with data 
from the sixth survey of the Tromsø Study (Tromsø 6). 
3.2.2 The Tromsø Study 
The Tromsø Study is a population-based general health study in the largest city in 
Northern Norway [122]. Since the study was initiated in 1974, repeated cross-sectional 
surveys have been carried out.  Tromsø 6 took place in 2007-2008. In this survey, 
19,762 inhabitants in Tromsø aged ≥30 years were invited to participate. In the age 
group 60-87, all inhabitants were invited. In total, 12,984 men and women participated 
(66%). The response rate was highest among men aged 65-69 (78%) and lowest among 
the oldest men aged ≥85 (28%) [123]. In this work, 1768 out of 2757 invited men aged 
65 to 87 years (68%) were included.    
                
        
3.3 The Birkebeiner Atrial Fibrillation Study  
 
As the Birkebeiner Ageing Study was not originally designed to study AF, to further 
investigate the association between prolonged endurance exercise and risk of AF, a 
second study was designed: The Birkebeiner Atrial Fibrillation Study. The papers II, III 
and IV are based upon this study. Figure 2 illustrates the inclusion process of the 
Birkebeiner Atrial Fibrillation Study. The study population of this retrospective cohort 
study comprises two distinct cohorts: 1) A cohort of veteran cross-country skiers aged 
≥53 years who had been participating in the Birkebeiner race (different from the cohort 
of the Birkebeiner Ageing Study), and 2) a subset of participants in the population-based 
Oslo Health Study.  
During June 2012, all 7500 invitees in the Birkebeiner Atrial Fibrillation Study received 
a questionnaire together with an invitation letter. The questionnaire was identical for all 
participants, regardless of which cohort they were recruited from. A first reminder was 
sent out to 3505 non-responders during September the same year. In addition, 888 
individuals who had filled out and sent in the questionnaire but not completed the 
consent form were reminded. A second reminder was sent out during December 2012.  
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3.3.1 The cohort of veteran cross-country skiers 
Based on result lists provided by the race organizer, all men and women who had 
participated in the Birkebeiner race in 1999, were aged ≥40 years at that time and had a 
Norwegian postal address were invited to take part in this study. Among 3485 invited 
skiers, 2653 (76%) responded. Among 3114 invited male skiers, 2366 (76%) men 
participated in the study. In total, 286 out of 371 (77%) invited female skiers took part 
in the study. In order to cover the range of exposure from physical inactivity to 
prolonged regular endurance exercise, the cohort of veteran skiers was combined with a 
subset from The Oslo Health Study.  
3.3.2 The Oslo Health Study cohort 
The Oslo Health Study was an age-stratified population-based health study [124]. Men 
and women aged ≥53 years (born in 1924, 1925, 1940, 1941, 1954 and 1955) who 
participated in the second survey of the Oslo Health Study in 2009 and had given 
consent to be re-contacted for further studies were invited to take part in the 
Birkebeiner Atrial Fibrillation Study. Out of 5982 individuals who had not reported 
heart rhythm disturbances in the 2009 survey, 3000 were randomly selected and invited 
to take part in the study. In addition, all 1013 individuals who had reported heart 
rhythm disturbances were invited, in order to maximize the number of endpoints. In 
total 2737 out of 4013 invited men and women from the Oslo Health Study (68%) 
participated in the Birkebeiner Atrial Fibrillation Study. In total, 1179 out of 1885 
invited men (71%) and 1393 out of 2130 invited women (65%) responded. 
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Figure 2. Recruitment of participants to the Birkebeiner Atrial Fibrillation Study, based 
upon two distinct cohorts.  
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4 METHODS 
The data used in the Birkebeiner Ageing Study are entirely based on information 
obtained by questionnaires. When designing the questionnaire to this study, we chose 
questions that had been used in the Tromsø Study, in order to allow comparing analyses.  
The data in the Birkebeiner Atrial Fibrillation Study were mainly obtained by 
questionnaires, but in 416 individuals with self-reported AF, hospital medical records 
were reviewed in order to confirm the AF diagnoses. English translations of the 
questionnaires are included in the appendix of this thesis.  
4.1 Assessment of the main outcome atrial fibrillation 
The main outcome of the papers I, II and III was AF. AF was measured differently in the 
three papers: In the papers I and III, AF was self-reported by questionnaires. In paper II, 
AF and AFL confirmed by ECG in the review of medical records were the main outcomes, 
while AF that was self-reported by questionnaires was a secondary outcome. Lone AF 
was another secondary endpoint of paper II.  
4.1.1 Self-reported atrial fibrillation 
In the Birkebeiner Ageing Study, AF was defined as positive response to the question Do 
you have or have you had atrial fibrillation?  
In the questionnaire of the Birkebeiner Atrial Fibrillation Study, AF was assessed with 
two questions: Do you believe yourself that you have or have had atrial fibrillation? and 
Have you been diagnosed as suffering from atrial fibrillation by a doctor? In this study, we 
also included questions regarding the first AF diagnosis, subtype of AF and frequency of 
symptoms. AFL and other supraventricular tachycardia (SVT) were not assessed in the 
questionnaire but registered during the review of medical records. 
4.1.2 Atrial fibrillation confirmed by ECG 
When available, medical records were reviewed according to a predefined protocol for 
subjects who reported AF in the questionnaire of the Birkebeiner Atrial Fibrillation 
Study, stated a Norwegian public hospital as the place where AF had been diagnosed and 
gave consent. Among 694 study participants with self-reported AF, 574 (83%) gave 
consent to the review of their medical records. 92 participants reported that AF been 
diagnosed by their general practitioner (GP). Initially, we tried to identify and get access 
to these out-of-hospital medical records. However, this turned out to be a difficult task 
because the cases were distributed among very many GPs across Norway and because 
many of the GPs lacked routines for use of patient data in research. Some of the 
participants had been diagnosed abroad and some did not name the hospital where AF 
had been diagnosed, leaving 472 who had also named a hospital. In the end, records 
were available for review in 416 out of these 472 (88%) individuals.  
The review of medical records in 18 different hospitals took place in the period between 
February 1st and June 1st 2013. Incident arrhythmias (AF, AFL, other SVT, 
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atrioventricular block, ventricular tachycardia) up until 31.12.2012 were identified by 
ECGs. In cases of uncertain diagnoses, an endpoint committee consisting of two 
experienced cardiologists was consulted. In 19 cases where an ECG could not be found, 
diagnoses from the medical record text were used.  
AF was classified as “lone” if the review did not reveal other relevant diseases 
(concomitant heart diseases, diabetes mellitus or surgery or treated infection during the 
past seven days before AF diagnosis). In individuals with hypertension, the arrhythmia 
was classified as lone only if echocardiography findings were available and normal. 
4.2 Assessment of other outcomes  
The endpoints of paper IV were leisure-time PA during the past year, current 
engagement in regular endurance exercise, palpitations, functional capacity, drug use 
and subjective health.  
4.2.1 Leisure-time physical activity and endurance exercise 
We assessed leisure-time PA during the past year using the question State the movement 
and PA you engage in during your leisure time. If your activity level varies between 
summer and winter, note an average value. Tick the most appropriate box only. A five-
level scale was condensed into the four categories [3]: 1) Sedentary (reading, sitting still, 
other sedentary activity or light activities like walking, less than 4 hours per week); 2) 
Light PA (walking, cycling or other activity for at least 4 hours per week); 3) Moderate 
PA (recreational exercise, heavy gardening, for at least 4 hours per week); and 4) High 
PA (Regular hard exercise or competitive sports several times per week). 
We specifically defined endurance exercise in the questionnaire as regular endurance 
exercise for at least 30 minutes at least three times per week with the purpose of 
increasing physical endurance capacity. The endpoint regular endurance exercise in 
paper IV was defined as positive response to the question Do you still engage in regular 
endurance exercise? 
4.2.2 Symptoms, drug use and subjective health 
Palpitations during the past year were assessed with the question Have you noticed 
sudden changes in your heart rate or heart rhythm in the past year?  
We used the NYHA functional classification (class I-IV) in order to assess functional 
capacity [125], and asked the participants to report how their heart disease impacts on 
their functional capacity (If you have a heart disease, how does it impact on your ability to 
function?) with four answer categories: I) No limitations. Ordinary PA does not cause 
undue fatigue, dyspnea or chest pain, II) Slight limitations of PA, but comfortable at rest. 
Ordinary PA results in fatigue, dyspnea or chest pain, III) Marked limitations of PA, but 
comfortable at rest. Even light PA causes fatigue, dyspnea or chest pain, and IV) Inability 
to carry out any PA without discomfort. Fatigue or chest pain may be present even at 
rest.  
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Drug use related to AF was assessed with the question Do you use the following 
medicines as a result of atrial fibrillation? with the following possible answers: Beta-
blockers (e.g. Selo-Zok, Metoprolol, Sotalol, Sotacor, Emconcor), calcium-blockers (e.g. 
Isoptin, Verapamil, Veracard), amiodarone (Cordarone), flecainid (Tambocor), Digitoxin, 
digoxin (Lanoxin), acetylsalicylic acid (Albyl-E, Magnyl-E), dronedarone (Multaq), 
warfarin (Marevan) and dabigatran (Pradaxa). 
Finally, we assessed subjective health with the question How do you rate your own 
health? with four answer categories (Poor, fair, good and very good) [126].  
4.3 Assessment of the main exposure endurance exercise 
Under the assumption that participation in a long-distance cross-country ski race when 
aged ≥65 years requires regular endurance exercise, endurance sport practice in the 
Birkebeiner Ageing Study was defined as belonging to the cohort of veteran cross-
country skiers. 
In the Birkebeiner Atrial Fibrillation Study, endurance exercise was specifically defined 
in the questionnaire as regular endurance exercise for ≥30 minutes at least three times 
per week with the purpose of increasing physical endurance capacity. The first question 
regarding endurance exercise used in the questionnaire, was Have you ever been 
practicing regular endurance exercise? (yes/no). Thereafter, the participants were asked 
to report the cumulative number of years they had been exercising regularly on an eight-
level scale: Never, <5, 5-9, 10-19, 20-29,30-39, 40-49, 50-59, ≥60 years. In paper II, the 
scale was condensed from eight into five categories with cut-off at 40 years of exercise. 
In paper III, the scale was condensed into only four categories due to the lower number 
of women exposed to exercise in the study. Participants who had not answered any of 
these two questions were assumed not to have been exercising regularly and given the 
value Never. 
4.4 Covariates 
All covariates were self-reported by questionnaires. Diseases were assessed with the 
question Do you have or have you had (name of the disease)? In addition to age, gender, 
height and weight, we assessed the following established AF risk factors in the 
questionnaires of both the Birkebeiner Ageing Study and the Birkebeiner Atrial 
Fibrillation Study: Concomitant heart diseases (myocardial infarction, angina pectoris, 
heart valve pathology and heart surgery), hypertension, diabetes mellitus and 
hyperthyroidism. We also assessed the following less established risk factors and other 
possible confounding factors in both studies: Lipid-lowering treatment, stroke, use of 
tobacco and alcohol, education and marital status. We calculated BMI based on self-
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reported height and weight. In paper IV, we estimated CHA2DS2-VASc score using age, 
sex and self-reported CHD, hypertension, stroke and diabetes mellitus [84]. 
We used direct acyclic graphs (DAGs) to identify covariates appropriate for adjustment 
in all regression analyses. DAGs are causal graphs that summarize all relevant causal 
relations between an exposure and an outcome, and is a tool in the analysis of causal 
associations [127]. Causal graphs do not prove causality, but are based upon causal 
thinking and define a main exposure and a main outcome. In DAGs, covariates are 
defined as confounders, mediators or colliders. In the regression analyses, adjustments 
are made for confounders, but not for colliders. Mediators are adjusted for when aiming 
to estimate the direct effect between exposure and outcome. 
 
 
4.5 Statistical analyses 
 
Although having observed a higher AF prevalence in the Birkebeiner Ageing Study, we 
assumed a prevalence of 5% in the power calculation of the Birkebeiner Atrial 
Fibrillation Study, due to a lower expected mean age of this study population. In order to 
find an OR of 1.5 with a 95% CI with a power of 80%, in a study where 50% were 
exposed to exercise and the prevalence of AF was 5%, around 5000 subjects were 
required. 
We used Student’s t-test for means of continuous variables and Pearson’s Chi square of 
independence for categorical variables to compare characteristics of the study 
participants. In paper I, a linear regression analysis was used to calculate crude (cRDs) 
and aRDs with CIs and a logistic regression analysis was used to calculate the aOR with 
CI. In paper II, III and IV, aORs with CIs were calculated by logistic regression analyses. 
We tested all relevant covariates, but included only established risk factors and 
covariates changing the estimates with ≥10% in the final models. 
In paper II and III, we adjusted for different selection probabilities by using inverse 
probability weighting: Study participants who were invited because they had previously 
participated in the Birkebeiner race or because they had previously reported 
arrhythmias in The Oslo Health Study were weighted by one (all eligible individuals 
were invited). Participants who were randomly selected among participants in the Oslo 
Health Study were weighted by two (3000 out of 5982 were invited). Due to the 
different selection probability, we reported the weighted prevalence for the participants 
in the Oslo Health Study in paper II, and weighting was used in all regression analyses of 
paper II and III.  
In the papers II and III, we excluded study participants who had been invited because 
they had reported hearth rhythm disturbances in the Oslo Health Study but turned out 
not to have any arrhythmias. In paper III, we excluded women aged >75 years in order 
to reduce recall bias. In order to increase the comparability between the AF 
subpopulations of the study, we excluded individuals aged >85 years in paper IV. Due to 
the strong positive relation between age and risk of AF, we performed sensitivity 
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analyses after exclusion of men aged >75 years to explore the influence of age 
distribution on the risk estimates in paper II. In addition, sensitivity analyses after 
exclusion of men diagnosed with arrhythmia before the age of 40, men invited because 
they had previously reported heart rhythm disturbances and men with self-reported AF 
but unavailable medical records were conducted. In paper II we reported estimates for 
the two distinct cohorts (Birkebeiner skiers and participants from the Oslo Health 
Study) separately and for the whole study sample. 
All statistical analyses were conducted using SPSS version 20.0 (IBM, Armonk, New 
York, USA) or STATA version 12.1 (StataCorp LP, Lakeway Drive, Texas, USA). 
4.6 Ethical considerations 
The studies in this thesis were approved by the Regional Committee for Medical and 
Health Research Ethics (REK) and comply with the Declaration of Helsinki. Together 
with the questionnaires, all invitees received invitation letters that had been approved 
by REK. Informed written consents to participate in the study were obtained. The review 
of medical records was only performed for participants who had actively given a written 
informed consent to the review. Approvals for the review of medical records were 
obtained from the responsible authorities for research and data protection for each 
hospital reported by at least one participant. Inclusion in the studies was considered not 
to have any harmful effects for the participants.  
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5 RESULTS 
5.1 Paper I: Endurance sport practice as a risk factor for atrial 
fibrillation 
Title: Increased risk of atrial fibrillation among elderly Norwegian men with a history of 
long-term endurance sport practice 
Compared to men of the same age from the general population of Tromsø, veteran cross-
country skiers aged ≥65 years (mean age 69, range 65-90 years) had a low prevalence of 
the established AF risk factors CHD, hypertension and diabetes mellitus. The crude 
prevalence of AF was 13.2% in the veteran athletes and 11.6% in the general population. 
The prevalence of AF after exclusion of persons with CHD was 13.0% in the veteran 
athletes and 9.8% in the general population. After multivariable adjustment for age, 
height, BMI, CHD, hypertension, diabetes mellitus, smoking, alcohol consumption, 
leisure-time PA during the past year and education, endurance sport practice gave an 
added risk of AF of 6 pp (aRD 6.0 (CI 0.8-11.1)), corresponding to an aOR of 1.90 (CI 
1.14-3.18). The risk of AF increased with 0.4 pp per added year of age and with 0.3 and 
0.6 pp per cm of height and unit of BMI added, respectively. Also hypertension and CHD 
were significantly associated with an added risk for AF. 
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5.2 Paper II: Years of regular endurance exercise was associated with 
a graded increased risk of atrial arrhythmias in men 
Title: Effect of years of endurance exercise on risk of atrial fibrillation and atrial flutter 
The prevalence of self-reported AF was 12.5% among the veteran cross-country skiers 
(mean age 66, range 53-92 years) and the weighted prevalence among the participants 
in the Oslo Health Study was 10.3%.  While AF was confirmed by ECG in 219 out of 306 
men (72%) with self-reported AF and available medical records, 52 (17%) had AFL. 
After multivariable adjustment for age, height, concomitant heart disease, hypertension, 
diabetes mellitus and cohort affiliation, cumulative years of regular endurance exercise 
were associated with a gradually increased risk of AF with an aOR for AF of 1.16 (CI 
1.06-1.28) per ten years of exercise, 1.16 (CI 1.00-1.36) among the skiers and 1.20 (CI 
1.06-1.35) among the men from the Oslo Health Study. Regular endurance exercise was 
also associated with a gradually increased risk of AFL. The aOR for AFL per ten years of 
exercise was 1.42 (CI 1.20 – 1.69) and did not differ between the two cohorts. The aORs 
per ten years of exercise were 1.26 (CI 1.10 to 1.44) for lone AF and 1.12 (CI 1.04-1.19) 
for self-reported AF.  
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5.3 Paper III: Prolonged endurance exercise might be associated with 
atrial fibrillation in women 
Title: Does endurance exercise cause atrial fibrillation in women? 
In total, 110 out of 1449 women reported AF. The prevalence of self-reported AF among 
female veteran cross-country skiers (n=278, mean age 62, range 53-75 years) was 8%. 
While 815 women had never exercised regularly, 634 had exercised regularly at some 
point of life, 89 of them for ≥40 years. Women who had never exercised regularly were 
older compared to women who had exercised at some point of life. Women who had 
exercised ≥20 years had a lower mean BMI and less hypertension and lipid-lowering 
treatment than women who had exercised <20 years. After multivariable adjustment for 
age, BMI, concomitant heart disease, hypertension, diabetes mellitus and cohort 
affiliation, women who had exercised for ≥40 years seemed to have an increased risk of 
AF of borderline significance (aOR 2.18 (CI 0.94-5.06)) compared to women who had 
never exercised regularly. 
5.4 Paper IV: The majority of veteran athletes still engaged in regular 
physical activity and exercise after the onset of atrial fibrillation 
Title: Physical activity, symptoms, medication and subjective health among veteran 
endurance athletes with atrial fibrillation 
AF was reported by 322,  medical  records  were available for review for 177 and AF 
was  confirmed  in 140 veteran  cross-country  skiers. Among the study participants 
from the general population, AF was confirmed in 118 cases. Among veteran skiers, 
52% had paroxysmal AF, 23% had persistent AF and 24% had permanent AF, while 
the corresponding proportions in the general population were 52%, 17% and 30%. 
Veteran athletes with AF were older and had a higher prevalence of  co-morbid  
conditions than veteran athletes without AF, but were younger and had a lower BMI 
and less co-morbidity than their counterparts with AF in the general population. Only 
11% of the veteran skiers with AF were inactive, 70% reported moderate or high PA 
during the past  year and  64% still  engaged  in  regular  endurance  exercise. After 
multivariable  adjustment for age,  sex, BMI,  co-morbid  conditions and number of 
completed Birkebeiner races, AF was associated with poor subjective health among 
veteran athletes (aOR 2.8 (CI 1.7-4.6)). Almost two out of three reported palpitations 
during  the past  year and  one out of  three  had  experienced  reduced functional 
capacity, but symptoms did not differ significantly between the veteran athletes with 
AF  and the general AF  population,  between  AF subtypes  or between AF with 
and without co-morbid conditions. One out of three with AF and an estimated 
CHA2DS2-VASc-score ≥2 was not treated with OAC. 
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6 DISCUSSION 
 
The results of this thesis support that endurance sport practice might be a risk factor for 
AF in men aged ≥65 years, suggest a graded positive association between years of 
regular endurance exercise and risk of atrial arrhythmias in men, and indicate that 
prolonged endurance exercise might be associated with an increased risk of AF also in 
women. In addition, it has been demonstrated that the majority of veteran athletes 
remains physically active and engage in regular endurance exercise even after the onset 
of AF. The study populations, including veteran athletes that on average have been 
exposed to regular endurance exercise and sport practice for very many years, 
confirmation of AF diagnoses during a review of medical records, very high attendance 
rates and the collection of a broad specter of possible confounding factors, are main 
strengths of these studies. Some important issues related to the study design, exposure 
and outcome measurements and confounding, however, will be discussed.  
 
 
6.1 Methodological considerations 
 
The observational design of the studies of this thesis has some important limitations. 
Observational studies can be hampered by selection bias, information bias and 
confounding. Furthermore, the design does not allow any conclusions about a causal 
relationship.   
6.1.1 Study design  
To conduct a randomized controlled trial in order to investigate the relation between 
prolonged endurance exercise and risk of AF, might seem unfeasible and would also 
have carried some ethical problems. Study participants would have to be followed 
prospectively for a long time, with high risk of drop-outs and problems with competing 
risk. Therefore, a retrospective study design appeared to be the most feasible in order to 
study this association. As it might be assumed that participation in the Birkebeiner race 
requires regular endurance exercise, the use of participation lists from the race 
organizer provides some objective information on the exposure, in addition to the 
retrospective self-reporting of exercise.  
In paper I, we used cross-sectional data from the Birkebeiner Ageing Study and the 
Tromsø Study. The main exposure was participation in the Birkebeiner race and the 
main outcome was self-reported AF. This study design might be affected by selection 
bias, because participation in the study might be associated with both the exposure and 
the endpoint: Individuals who had discontinued their endurance sport practice due to 
AF (or other diseases) did not have the opportunity to participate in the study. This 
“healthy exerciser effect” might have caused an underestimation of the AF prevalence 
among the veteran skiers and the AF risk estimates.  
Also in the Birkebeiner Atrial Fibrillation Study, we used cross-sectional data. In this 
study, however, the study population was based upon a cohort of veteran skiers that had 
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been participating in the Birkebeiner race many years earlier (1999) and the study 
might be characterized as a retrospective cohort study [128]. Because AF is uncommon 
before the age of 40 and all skiers who were aged ≥40 in 1999 were invited, the results 
of this study are less likely to be affected by a “healthy exerciser effect”. On the other 
hand, individuals with AF who had been exposed to endurance exercise might have been 
more prone to participate in the study, and this possible selection bias might have 
caused an overestimation of the risk estimates. However, as high attendance indicates 
that the study population gives satisfactory information about the target population 
[129], the risk of an overrepresentation of AF cases is reduced by the high attendance 
rate in the study. Even in studies with much lower attendance rates, it has been 
demonstrated that effect estimates are not necessarily biased by under- or 
overrepresentation of the exposure [130, 131]. 
While inadequate control groups and the lack of a reference point in the general 
population have been pointed out as a weakness of previous studies [111, 132], in the 
Birkebeiner Atrial Fibrillation Study we combined two distinct cohorts with the aim to 
cover the whole range of exposure from physical inactivity to prolonged endurance 
exercise. The combination of two cohorts that differ in many aspects might be 
questioned, because unmeasured cofounding like psychosocial factors and a family 
history of cardiovascular diseases could influence the risk of AF [133, 134]. However, 
the association between years of exercise and risk of AF was consistent also when the 
two cohorts were analyzed separately (paper II). 
The low number of female participants confines the possible gender perspectives of the 
Birkebeiner study populations. Female response rates were at the same level as in men, 
but the low proportions of women participating in our studies reflect that women 
represent a minority among veteran athletes participating in long-distance cross-
country ski races. 
6.1.2   Atrial fibrillation measurements  
AF studies are limited by the natural course of the disease. Firstly, 30-40% of the 
individuals with AF might be asymptomatic [135-137]. Secondly, in individuals with 
paroxysmal AF, the arrhythmia can only be diagnosed with certainty during an attack. 
Thus, AF studies are likely to have high rates of AF cases that are misclassified as 
without arrhythmia (low sensitivity). The proportion of persons with undiagnosed AF 
might be especially high in our study populations, as old people often have less 
symptomatic AF than younger [137-139]. Self-reported AF was the main endpoint in 
paper I and paper III. As demonstrated in figure 1, the prevalence of AF was higher in 
Tromsø 6, where AF was self-reported, compared to other prevalence studies. High 
sensitivity might be an advantage of self-reporting of AF, as also undiagnosed cases are 
counted, but a limitation of our studies is that we did not investigated the sensitivity of 
the AF measures. 
A key question is whether the misclassification is differential and associated with the 
exposure. Physically inactive individuals might be less likely to experience AF symptoms 
[137], and active individuals might recognize symptoms earlier inactive individuals. This 
might have caused an overestimation of the associations between exercise and sport 
practice and AF. On the other hand, athletes more often have typical vagal AF with lower 
heart rates and paroxysms during night [118, 140], and might be more prone to ignore 
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symptoms. Athletes also more often have paroxysmal AF that might be more challenging 
to diagnose [118], and this might have caused an underestimation of the studied 
association.  
A strength of the Birkebeiner Atrial Fibrillation Study is that AF diagnoses were 
confirmed in a review of medical records. Table 3 shows confirmed arrhythmias 
according to the two questions used in the questionnaire of the Birkebeiner Atrial 
Fibrillation Study. Among participants with self-reported AF, the diagnosis was 
confirmed in three out of four, while around 16% had other arrhythmias. In 11% the 
review did not reveal any arrhythmia. The positive predictive value (PPV) of a positive 
response to the question Do you believe yourself that you have or have had atrial 
fibrillation? was 73% for AF, but 81% when AF and AFL were analyzed together. The 
PPV was lowest in the subgroup that was unexposed to regular endurance exercise. This 
indicates that AF might be overestimated in the reference group and that the association 
between exercise and self-reported AF might be underestimated. The PPV did not differ 
largely between the two questions Do you believe yourself that you have or have had 
atrial fibrillation?  and Have you been diagnosed as suffering from atrial fibrillation by a 
doctor? However, we assumed a higher sensitivity for the first question and chose to use 
positive response to this question as an endpoint in the papers of this thesis. 
AF and AFL confirmed by ECG were the main outcomes in paper II. Medical records were 
available for 60% of the individuals with self-reported AF. The proportion with available 
records among those with self-reported AF did not differ between skiers and non-skiers, 
but were slightly higher in individuals who reported ≥30 years of regular exercise 
compared to the other groups of exposure. This might have caused an overestimation of 
the risk estimates in the highest categories of exercise. On the other hand, non-athletes 
have higher prevalence of co-morbid conditions and the individuals with the lowest 
exposure to exercise might therefore have been more likely to be hospitalized for any 
reason. Because AF diagnoses were confirmed using in-hospital medical records, the 
association between exercise and AF might be underestimated. 
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Table 3: Proportions with arrhythmias confirmed in the review of medical records 
(positive predictive values) among individuals with self-reported atrial fibrillation 
according to the two different question used in the Birkebeiner Atrial Fibrillation Study 
(n=416).  
 
 n a Results of the review, numbers and proportions (%) 
 No 
arrhythmia 
Atrial 
fibrillation 
Atrial 
flutter 
Other  
SVT b 
Other 
arrhythmias 
Do you believe yourself that 
you have or have had atrial 
fibrillation?   
351 40 
 
11.4 
255 
 
72.6 
28 
 
8.0 
21 
 
6.0 
7 
 
2.0 
Have you been diagnosed as 
suffering from atrial fibrillation 
by a doctor? 
365 39 
 
10.7 
270 
 
74.0 
 
29 
 
7.9 
20 
 
5.5 
7 
 
2.0 
a Number of review medical records among study participants who answered this question positively, gave consent 
to the review and named a Norwegian hospital where atrial fibrillation had been diagnosed.  
b Supraventricular tachycardia  
 
 
While most previous studies have not differentiated between AF and AFL [8, 9, 141], the 
differentiation between these two atrial arrhythmias is an asset of our study. Subjective 
distinguishing between AF and AFL, however, can be difficult and AFL was not assessed 
in the questionnaire. Individuals who knew that they had been diagnosed with AFL and 
not AF might have answered “no” on the questions regarding AF, leading to an 
underestimation of the AFL risk estimates.   
While some previous studies have used hospitalization recorded with ICD-10-codes in 
national in-patient registers [142, 143], others have used self-reported AF and obtained 
medical records for confirmation of the diagnosis [106, 144]. In order to isolate lone AF, 
prescription of flecainid and sotalol recorded from the Norwegian prescription registry 
was used as a surrogate measure for lone AF in one study [145]. All measures have 
limitations and comparison of results between studies is difficult. Even in studies where 
AF has been diagnosed using the gold standard ECG [103, 108, 109], false negative rates 
have not been assessed and the overall validity is therefore unknown. The results of the 
Birkebeiner Atrial Fibrillation Study are strengthened by the consistency between the 
various AF measures used in the study. 
6.1.3 Measurements of other endpoints  
A limitation of our studies is that we did not assess other symptoms than palpitations 
and functional capacity. Palpitations are, however, the most commonly reported among 
AF-related symptoms [72], and might be more specific than for example dyspnea. The 
NYHA-classification measures the physical functional capacity and was originally 
developed for use in heart failure patients, but has also been validated in AF patients 
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[72, 125]. It assesses functional capacity related to fatigue, shortness of breath or chest 
pain, and therefore gives some information also about these AF-related symptoms.  
Self-reports of OAC use might provide imprecise information on adherence [87]. 
Furthermore, the Birkebeiner Atrial Fibrillation Study do not provide information on the 
use of novel OACs because these were not in routinely use in Norway at the time of the 
study [146].  
Self-rated health is a reliable and valid measure of subjective overall health status, 
including biological, psychological and social dimensions of health, and is associated 
with morbidity and mortality [126, 147, 148]. It has also been used previously in studies 
of AF patients [73]. 
6.1.4 Measurement of endurance exercise 
In paper II and III, we aimed to investigate a dose-response relationship in the 
association between endurance exercise and risk of AF and designed our own questions 
and scales in order to assess prolonged endurance exercise. We used an eight-level scale 
with a cut-off at 60 years of exercise. Thus, at least partly, the exposure occurred many 
decades ago and might have been difficult to recall accurately. Furthermore, the results 
might have been affected with recall bias: Participants with AF might have been more 
prone to over-report previous exercise than individuals without AF, causing a 
differential misclassification that could have influenced the effect estimates positively.  
6.1.5 Measurement of co-morbid conditions and confounding 
Confounders are variables that are associated both with the exposure and the outcome 
[128]. While the results of previous studies investigating the risk of AF by endurance 
sport practice have been questioned because many of the participants have been 
exposed to possible confounding factors [102, 103], the prevalence smoking and co-
morbid conditions was relatively low in our studies. Furthermore, the assessment of a 
broad specter of AF risk factors, co-morbid conditions and other possible confounding 
factors is an asset of both the Birkebeiner Ageing Study and the Birkebeiner Atrial 
Fibrillation Study. Although self-reporting might be affected by recall bias, previous 
studies suggest an acceptable validity of self-reported data on diseases like CHD, 
hypertension [149], diabetes mellitus and stroke [150], and smoking [151].  
In paper IV, we estimated CHA2DS2-VASc scores based on age, sex and self-reported 
CHD, hypertension, stroke and diabetes mellitus [84]. Congestive heart failure and 
vascular diseases others than CHD were not assessed in our questionnaire. This method 
provides only rough estimates for stroke risk, but was useful in order to assess the use 
of OAC in AF patients with concomitant stroke risk factors.  
 
6.2 Discussion of the main results 
 
6.2.1 Endurance sport practice as a risk factor for atrial fibrillation 
In the Birkebeiner Ageing Study (paper I), we demonstrated a high prevalence of AF of 
13.2% among male veteran cross-country skiers. This is in concordance with a previous 
study of veteran Birkebeiner skiers, where the prevalence of AF was 16.7%. [97]. A 
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higher prevalence of concomitant cardiovascular risk factors and diseases in the 
previous study might, at least partly explain the difference between the studies [99].  
Endurance sport practice, defined as participation in the Birkebeiner race, seemed to be 
a risk factor for AF among men aged ≥65 years. This result is in line with those from 
previous studies conducted in younger male elite orientation runners, former 
professional cyclists and non-elite marathon runners [8, 9, 103]. The result is also 
supported by the results of a recent study by Andersen, et al, conducted among Swedish 
participants in the 90-kilometer cross-country ski race Vasaloppet. In this study, men 
who had completed ≥three races had a significant higher risk of AF, with an adjusted 
hazard ratio (HR) of 1.27 (CI 1.02–1.57) compared with participants who had only 
completed one race [142]. A main limitation of this study was the lack of a reference 
point in the general population [132]. The aRD estimated in the Birkebeiner Ageing 
Study corresponds to an aOR for AF of 1.90 (CI 1.14-3.18). This is close to the risk 
estimate (pooled RR for AF 1.98 (CI 1.00-3.94)) reported in a recent meta-analysis that 
included almost 2,000 endurance athletes of different ages [152]. 
In a previous study conducted among men and women aged ≥65 years in the United 
States, leisure-time PA seemed to reduce the incidence of AF in a graded manner [112]. 
The most active group in this study, however, had an average activity level 
corresponding to 1840 kcal/week, which is likely to be far below that of the majority of 
Birkebeiner skiers. Our results are also in contrast with the Physician’s Health Study, 
where no association between endurance exercise and risk of AF was found among male 
physicians aged >50 years. The authors of this paper suggest an underestimation of the 
AF risk due to a “healthy exerciser effect”, or that older individuals exercise less 
vigorously than younger [106]. The stronger exposure to exercise in the Birkebeiner 
Ageing Study increases its power to detect an association between exercise and AF and 
is likely to explain the controversial results between ours and these previous studies.  
In a recently published study of cyclists in New Zeeland, no association was found 
between participation in a bicycle race and hospital admissions due to AF when 
compared to the general population [153]. In this study, the majority of participants 
were aged <50 years, only 66 cases of AF were registered and the study might therefore 
not have had enough power to detect an association. In an analysis derived from two 
large prospective studies of walkers and runners, cardiac arrhythmias were not related 
to walking or running intensity or to marathon participation or performance [154]. This 
study, however, did not differentiate between arrhythmias. 
6.2.2 Prolonged endurance exercise and risk of atrial fibrillation 
In the Birkebeiner Atrial Fibrillation Study (paper II), we demonstrated a gradually 
increased risk of AF by cumulative years of regular endurance exercise in men. A 
population-based cohort study published in 2014 supports a dose-response relationship 
between exercise and the risk of AF. More than 44,000 Swedish men aged 45-79 were 
included in this study, where weekly hours of exercise at age 30 were associated with an 
increased risk of AF later in life. Similar to in our study, the risk of AF seemed to increase 
gradually, but was not statistically significant until the highest level of exercise (>5 
hours exercise/week) [143]. The main strengths of this study were that it was 
conducted in a large cohort representing the general Swedish male population and had a 
high number of endpoints.  
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Elousa, et al, have suggested a threshold of 1500 lifetime hours of exercise for the 
development of AF [108]. However, as elite athletes in endurance sports might exercise 
around 1000 hours a year, and many non-elite athletes exercise 300-500 hours [155], a 
very high prevalence of AF should be expected with this estimated threshold. In 
contrast, Bjørnstad, et al, found no cases of AF in a follow-up study of Norwegian former 
elite athletes [101]. The result of paper II supports a gradually increased risk by amount 
of exercise rather than a threshold beyond where the risk of AF is increased. The AF risk 
was not statistically significantly increased until ≥30 years of exercise, but this might be 
due to lack of power of the study. Furthermore, in the light of individually different risk 
profiles, to set an absolute threshold seems unreliable.   
Few previous studies have differentiated between AF and AFL [116]. In our study, 13% 
of the male veteran athletes with confirmed AF also had AFL. Among the Finnish 
orientation runners studied by Karjalainen, et al, 25% had AFL in addition to AF [8]. In a 
study of Italian former professional cyclists, AFL was more common than AF [9]. The 
result of a retrospective case-control study including 61 Belgian patients with lone AFL 
suggested that a history of endurance sport practice may be a risk factor for AFL [156]. 
While these previous studies have not estimated the risk of AFL by endurance exercise, 
cumulative years of regular endurance exercise was associated with a graded increased 
risk of both AF and AFL in the Birkebeiner Atrial Fibrillation Study. This result suggests 
that the dose of endurance exercise might play a role in the pathophysiology of both 
arrhythmias.  
Despite a few negative studies and scepticism among some authors [102, 152, 157], 
others conclude that there is enough evidence to suggest a causal association between 
endurance sport practice and an increased risk of AF [116, 158-161]. However, many 
questions remain unanswered regarding the duration, amount, intensity and type of 
exercise that might increase the risk of AF [159].  
6.2.3 Prolonged endurance exercise and risk of atrial fibrillation in 
women 
Furthermore, the lack of data pertaining to women is a limitation of all previous studies 
[7, 118, 132]. In the Birkebeiner Atrial Fibrillation Study we investigated the association 
between endurance exercise and risk of AF in both genders. Although limited by weak 
power, the result of paper III indicates that prolonged endurance exercise might be 
related to an increased risk of AF also in women.  
The lack of an association between endurance exercise and sport practice and risk of AF 
in women in previous studies might either have epidemiological explanations or be due 
to real gender differences. As demonstrated in figure 1, women experience AF five to ten 
years later than men, and low numbers of AF cases in previous studies might at least 
partly explain why no association has been demonstrated between exercise and AF in 
women previously. This is illustrated by the study of participants in Vasaloppet, where 
only 12 cases of AF occurred during >50,000 person-years of follow-up among women 
[142]. The INTERHEART-study showed that also CHD occurs later in women than in 
men [69]. In the Birkebeiner Atrial Fibrillation Study, women were younger and had 
lower prevalence of CHD, hypertension and diabetes than men, and lower prevalence of 
established AF risk factors is likely to be part of the explanation.  
45 
 
Also gender differences in the exposure to endurance sport practice might play a role. 
The low proportions of women among the veteran skiers in our studies (7.8% in the 
Birkebeiner Ageing Study and 10.6% in the Birkebeiner Atrial Fibrillation Study) 
demonstrate that women are less likely to participate in endurance sports events. This is 
supported by the results of a study conducted among Danish people who exercised 
regularly, where only 22% of the women compared to 37% of the men had participated 
in endurance sports competitions [162].  In the same study, 5% of the women compared 
to 10% of the men exercised >10 hours per week. In a study of Danish runners, 18% of 
the women compared to 34% of the men reported an average weekly running distance 
of >30 kilometres, while 2.5% and 10.1% reported a distance of >50 kilometres [163].  
Finally, physiological gender differences might be part of the explanation. Women have 
physiological smaller hearts and higher heart rates, and low heart rates seem to predict 
AF only in men [145, 164]. Atrial morphological and functional changes have been 
demonstrated in female athletes [165], but in a recent study, female veteran athletes had 
less pronounced remodeling, lower sympathetic tone and lower blood pressure than 
their male counterparts [166]. The interplay between endurance exercise, sex hormones 
release and electrophysiological gender differences remains an unexplored field. 
6.2.4 Characteristics of atrial fibrillation in veteran athletes 
Paroxysmal lone AF in middle-aged men exposed to prolonged endurance exercise has 
previously been characterized as the typical clinical profile of exercise-related AF [116]. 
In the Birkebeiner Atrial Fibrillation Study of male skiers with a mean age of 69 years, 
24% had permanent AF and 43% had co-morbid conditions, indicating that veteran 
athletes with AF represent a more heterogeneous subpopulation. 
The clinical presentation of AF might vary between AF subtypes and between men and 
women, and is influenced by age, co-morbidity and socioeconomic status [72]. 
Furthermore, the lack of standardized outcome parameters in many AF studies limits 
the possibility of comparison between studies [135].  Palpitations and reduced 
functional capacity were less frequent both in veteran skiers and in the general AF 
population in the Birkebeiner Atrial Fibrillation Study than in previous studies 
conducted in general AF populations [74, 167]. While 60% had symptoms that required 
termination of sport activity in a study of 30 Dutch athletic men with paroxysmal AF 
[141], the high proportion engaging in exercise also after the onset of AF in our study 
supports that many individuals with AF have relatively mild symptoms [137]. Still, AF 
was associated with poor subjective health among veteran skiers. While this association 
was robust also after adjustment for co-morbid conditions in a previous study [73], 
subjective health seemed to depend on co-morbidity in the Birkebeiner Atrial 
Fibrillation Study.  
Both among the skiers and in the general population in the Birkebeiner Atrial 
Fibrillation Study, two out of three with AF and an estimated CHA2DS2-VASc score ≥2 
used OAC. Although the CHA2DS2-VASc score is roughly estimated in this study and self-
reporting might provide imprecise information on treatment adherence [87], the result 
might indicate a lower OAC use in our study populations compared to other general AF 
populations [168]. In general, veteran athletes might be less prone to any drug 
treatment [118], but there are no data to support not to treat veteran athletes with AF 
and a CHA2DS2-VASc score ≥2 with OAC in order to prevent stroke. 
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The proportion using rate-controlling drugs was lower in the veteran skiers with AF 
compared to the general AF population in our study. This might be due to lower heart 
rates in athletes, or because athletes refuse to use treatment that might reduce sports 
performance [118]. On the other hand, the proportion using rate-controlling drugs was 
higher than in a previous study conducted in France during the 1990’s [169]. This might 
reflect differences in symptom burden, co-morbidity and general health status or in AF 
medication prescription between countries and over time. 
6.2.5 Physical activity and endurance exercise in veteran athletes with 
atrial fibrillation 
Almost 90% of the veteran athletes were physically active also after the onset of AF, and 
two out of three still engaged in regular endurance exercise. Importantly, this 
demonstrates that veteran athletes continue to profit from the benefits of PA and 
exercise also after the onset of AF. In a short term, regular exercise might reduce resting 
heart-rates and symptoms and improve heart rate variability, exercise capacity, the 
ability to carry out activities of daily living and health-related quality of life in persons 
with AF [170-172]. In the long term, also individuals with AF can profit from the 
universal benefits of regular PA and exercise in terms of reduced mortality and 
morbidity [40].  
6.2.6 General discussion 
The exposure to PA or exercise varies largely and might explain the controversial results 
between studies. While large prospective cohort studies have typically investigated the 
risk of AF by self-reported PA [112, 113, 144], case-control and cohort studies with 
smaller sample sizes have been conducted in different populations of athletes [8, 9, 103]. 
The term “athlete” refers to individuals engaging in regular sport practice, but there is a 
wide gap between recreational exercise and elite level competitive sports, and a clear-
cut definition has not existed. Furthermore, physiological adaptions to endurance 
exercise might differ between individuals engaged in PA and athletes exposed to 
prolonged regular endurance exercise, and a threshold between physiological and 
pathological adaptions has not been established [7]. 
The results of paper I indicate that light or moderate PA during the past year might 
reduce the risk of AF. This result was not significant in our study, but is supported by the 
results of a Swedish study that demonstrated a reduced risk of AF by amount of PA 
among men with a mean age of 60 years [143], and those from the Cardiovascular 
Health Study (90), where self-reported PA was associated AF in a U-shaped manner in 
men and women aged ≥65 years. While moderate intensity was associated with lower 
incidence of AF (HR 0.72, CI 0.58-0.89), those who reported the highest activity level had 
the same AF incidence as the inactive individuals. Two studies that investigated the 
association between PA and risk of AF in women exclusively, demonstrated that higher 
levels of PA were associated with a lower prevalence of AF [144, 173]. In contrast, two 
recent meta-analyses conclude that there is no association between leisure-time PA and 
risk of AF [152, 174], and a Norwegian study by Thelle, et al, suggest an increased risk of 
AF in absence of concomitant heart disease (lone AF) by self-reported leisure-time PA at 
age 40 [145]. 
While endurance exercise seems to increase the risk of AF, PA might reduce the risk 
through a preventive effect on AF risk factors like CHD, hypertension and diabetes 
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mellitus (Figure 3). Therefore, the prevalence of risk factors others than exercise in the 
studied population will influence the estimated association between exercise and AF. In 
older populations, where these risk factors are likely to be more prevalent than in 
younger populations, a stronger AF risk reduction by PA might be expected. This might 
be important also after adjustment concomitant diseases, as cardiovascular conditions 
might be unrecognized in many studies.  
There is a strong positive association between age and risk of AF [68]. At the same time, 
older individuals are more likely to report a high number of years of cumulative years of 
exercise than younger. The prevalence of AF was higher than expected in the youngest 
and lower than expected in the oldest participants of the Birkebeiner Atrial Fibrillation 
Study, and the effect estimates increased slightly in the sensitivity analysis performed 
after exclusion of men aged >75 years. This supports that our results are not an effect of 
increasing age. 
 
 
 
Figure 3. Simplified direct acyclic graph (DAG) illustrating the association between 
physical activity and endurance exercise and atrial fibrillation. 
 
Arrows and covariates not influencing the analysis are excluded. The highlighted arrow illustrates the 
direct association between sport practice and atrial fibrillation. The other arrows illustrate intermediate 
covariates in the association (blue), confounding (red) and colliding (violet) covariates. 
 
 
 
 
48 
 
Endurance sports like cross-country skiing are highly dynamic sports characterized by a 
high cardiovascular demand during exercise and competition. During dynamic exercise 
there is an increase in heart rate, stroke volume, cardiac output and systolic blood 
pressure [4]. Mechanisms for AF in endurance-trained individuals are not fully 
understood, but myocardial remodeling and left atrial dilatation related to high volumes 
and pressures during exercise, atrial fibrosis caused by inflammation, increased vagal 
tonus and electrolyte disturbances during exercise are among the suggested 
mechanisms [116, 118, 158, 175]. A summary of factors that might influence the 
development of AF in athletes is shown in figure 4.  
 
 
 
 
Figure 4. Synopsis of factors that might influence the development of atrial fibrillation 
in athletes, from Wilhelm [158]. 
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Structural myocardial changes like dilatation or fibrosis could cause electrical 
dissociation between cardiac muscle bundles, and such local electro-anatomical 
substrates might facilitate re-entry circuits that can induce or maintain arrhythmias 
[66]. Studies have demonstrated an increase in myocardial biomarkers after endurance 
sport practice, suggesting an acute effect on the heart, possible caused by volume 
overload [158, 176]. Other studies have showed that left atrial dilatation is prevalent in 
many athletes and suggested that this might be a result of chronic exposure to high 
pressures and volumes [98, 103, 109, 177]. Among veteran Birkebeiner cross-country 
skiers, left atrial dilatation was identified as a marker for AF [97], but as AF itself might 
cause atrial dilatation, a causal relationship between atrial remodeling and AF in veteran 
skiers has not been established. Myocardial edema and inflammation after endurance 
exercise or competitions have been suggested as underlying mechanisms for myocardial 
fibrosis in athletes [178, 179].  
Finally, the autonomic nervous system seems to play a role. Endurance sport practice is 
associated with vagal or parasympathetic pre-dominance with low resting heart rates 
[180]. A high vagal tone might facilitate macro re-entry circuits in the atria by 
shortening of  the atrial refractory period [140, 158], and low heart rates predict AF in 
men [164]. In a recently published animal study, prolonged endurance exercise was 
associated with an increased sensitivity to cholinergic stimulation in atrial cardio 
myocyte potassium channels, that seemed to be mediated through mRNA (messenger 
Ribonucleic acid) down-regulation of potassium-channel-inhibiting RGS (Regulators of 
G-protein signaling) proteins [181]. This study supports that enhanced vagal activity 
plays a central role in the pathophysiology of AF in endurance-trained individuals. 
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7 CONCLUSIONS 
 
 
1. Endurance sport practice seemed to be a risk factor for AF in men aged ≥65 
years. 
 
 
2. Years of regular endurance exercise were associated with a gradually increased 
risk of both AF and AFL in men. 
 
 
3. Prolonged endurance exercise might be associated with an increased risk of AF 
also in women. 
 
 
4. AF was associated with poor subjective health, but the vast majority of veteran 
athletes engaged in regular PA and endurance exercise also after the onset of AF. 
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8 CONSEQUENCES OF THIS THESIS AND SUGGESTIONS FOR 
FUTURE RESEARCH 
 
 
8.1 Consequences of this thesis 
 
This thesis suggests that endurance sport practice and prolonged endurance exercise is 
associated with an increased risk of AF in men. It demonstrates that AF is prevalent also 
among female veteran athletes and indicates that prolonged endurance exercise might 
be associated with the risk of AF also in women.  
The literature suggests a complex association between PA, exercise and AF: For the vast 
majority of the general population, regular PA and exercise probably reduce the risk of 
AF [112, 119, 143, 144, 173]. On the other hand, this thesis indicates that prolonged and 
regular endurance exercise might increase the risk of AF gradually on the upper end of 
the activity range.  
It might be reasonable to inform veteran athletes about a possible increased risk of AF, 
also in the absence of established AF risk factors. At the same time, this thesis has 
demonstrated that AF do not prevent the majority of veteran athletes from profiting 
from the benefits of regular PA and exercise. This result supports that, despite a possible 
increased risk of AF by prolonged endurance exercise, general exercise restrictions 
should be avoided. Such restrictions could prevent individuals from taking advantage of 
the health promoting effects of PA and have adverse implications on a public health level 
[119, 182].  
Our current knowledge depends almost exclusively on observational studies, and many 
questions regarding the duration, intensity and type of exercise that might increase the 
risk of AF still remain unanswered. Meanwhile, the benefits of regular PA and exercise 
should be enhanced, and health care workers should recognize their strong 
responsibility to encourage individuals of all ages to engage in regular PA and exercise 
[183].  
 
 
8.2 Suggestions for future research 
 
Future studies of the association between endurance exercise and sport practice and the 
risk of AF should be prospective with a long follow-up period, include individuals across 
a broad range of exposure in order to investigate the optimal dose of exercise [132, 182], 
assess possible confounding factors and include both men and women. Furthermore, 
future research should focus on determining underlying mechanisms in the association 
between exercise and AF and include cardiac imaging, biomarkers of inflammation and 
myocardial fibrosis and electrophysiological studies. Furthermore, they should 
investigate long-term consequences of AF in veteran athletes. Future studies should 
include different subtypes of AF, individuals with different stroke risk profiles, record 
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co-morbid conditions and OAC and investigate the natural course of AF in athletes, 
incidence of stroke, heart failure, death and other cardiovascular endpoints.  
The participation in endurance sports events has increased, also among women. In this 
thesis we have demonstrated very high attendance rates in two study populations of 
veteran athletes. Events with shorter distances than marathons and long-distance cross-
country ski races are likely to attract more women, but also men that are less exposed to 
endurance exercise than participants in long-distance endurance events. Therefore, in 
order to gain a high attendance, a broad range of exposure and a sufficient number of 
female study participants, the use of participation lists from different endurance sports 
events might be a feasible method to recruit participants to further studies. Dependent 
on the study size and resources, health outcomes might be registered by self-reports, 
ECGs or national health registers, and outcome measurements should be validated, for 
instance by using handheld recording devices. 
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Atrial ﬁbrillation (AF) is the most common cardiac
arrhythmia. The prevalence increases with increasing
age. In middle-aged men, endurance sport practice is
associated with increased risk of AF but there are few
studies among elderly people. The aim of this study was
to investigate the role of long-term endurance sport
practice as a risk factor for AF in elderly men. A cross-
sectional study compared 509 men aged 65–90 years who
participated in a long-distance cross-country ski race
with 1768 men aged 65–87 years from the general popu-
lation. Long-term endurance sport practice was the
main exposure. Self-reported AF and covariates were
assessed by questionnaires. Risk differences (RDs) for
AF were estimated by using a linear regression model.
After multivariable adjustment, a history of endurance
sport practice gave an added risk for AF of 6.0 percent
points (pp) (95% conﬁdence interval 0.8–11.1). Light and
moderate leisure-time physical activity during the last
12 months reduced the risk with 3.7 and 4.3 pp, respec-
tively, but the RDs were not statistically signiﬁcant.
This study suggests that elderly men with a history of
long-term endurance sport practice have an increased
risk of AF compared with elderly men in the general
population.
Marathons and long-distance cross-country ski races
have become increasingly popular, also at higher
ages. Young and middle-aged male endurance athletes
seem to have an increased risk of atrial ﬁbrillation
(AF) (Karjalainen et al., 1998; Elosua et al., 2006;
Molina et al., 2008; Graff-Iversen et al., 2012; Müller-
Riemenschneider et al., 2012; Andersen et al., 2013) but
the role of endurance sport practice as a risk factor for
AF among elderly people has only been studied to a
small extent.
AF is the most common cardiac arrhythmia, with a
prevalence of 1.5–2% in the general population (Camm
et al., 2012). The prevalence increases with increasing
age, to 10% among 75-year-olds and between 15 and
20% in people aged over 85 years. The prevalence is
highest among men, around 15% by 75 years of age
(Heeringa et al., 2006; Tveit et al., 2008). The positive
association with age is partly explained by increasing
prevalence of risk factors for AF. Coronary heart disease
(CHD), hypertension and diabetes are among the most
important risk factors (Kirchhof et al., 2012), and are all
preventable by regular physical activity (PA).
However, it has been hypothesized that long-term
endurance sport practice facilitates structural changes in
the heart, increased vagal tonus and bradycardia, which
could predispose to AF (Calvo et al., 2012; Patil et al.,
2012; Turagam et al., 2012; Wilhelm, 2013). Many
elderly participants in long-distance endurance sports
events have been exposed to endurance sports for many
years. Elderly people might be more vulnerable than
younger people, due to CHD, hypertension and other
factors predisposing to AF, so that the association
between endurance sport practice and risk of AF might
be even stronger in this population. However, elderly
people with a history of long-term endurance sport prac-
tice might also have a lower risk of AF, due to the
protective effect of PA on important risk factors.
We are aware of only two studies that address the
association between leisure-time PA (LTPA) and risk of
AF in elderly people; the Cardiovascular Health Study
and the Physicians Health Study (Mozaffarian et al.,
2008; Aizer et al., 2009). Most participants in these
studies were less physically active than required for
endurance sport practice and neither of these studies
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demonstrated increased risk of AF associated with PA in
elderly people.
CHD among Norwegian long-distance cross-country
skiers was studied by Lie and Erikssen in the 1970s. They
found a low incidence among the skiers after 5 years
follow-up (Lie & Erikssen, 1984). After a 28–30-year
follow-up of the same cohort, Grimsmo et al. (2010)
demonstrated a high prevalence of AF among the elderly
skiers, but the skiers were not compared with a control
group.
The aim of our study was to investigate the role of
long-term endurance sport practice as a risk factor forAF
in elderly men, by comparing the prevalence of AF
among participants of a long-distance cross-country ski
competition with the prevalence of AF in the general
elderly population.
Materials and methods
Design and study populations
The Birkebeiner Ageing Study (BiAS) is a longitudinal study of
skiers aged 65 years and older participating in the Norwegian
Birkebeiner cross-country ski race, with the main purpose to study
associations between long-term exercise and health in advanced
age.With a course of 54 km and a total of about 1000 uphill altitude
meters, the Birkebeiner race is among the world’s most challeng-
ing. Based on result lists provided by the organizer, all 658 Norwe-
gian skiers aged 65 years and older who completed the race in 2009
or 2010 were invited to participate. A questionnaire and an invita-
tion letter were sent to the participants, and the completed question-
naire was returned by post. Due to low number of female
participants in BiAS, only men were included in this study.
In order to assess the association between endurance sport
practice and risk of AF, cross-sectional baseline data from BiAS
were comparedwith data from the sixth survey of theTromsø Study
(Tromsø 6) which took place in 2007–2008. The Tromsø Study is a
population-based general health study with repeated cross-
sectional surveys in the largest city in Northern Norway (Jacobsen
et al., 2012). In Tromsø 6, 19 762 inhabitants in Tromsø aged 30
years and older were invited. A total of 12 982 participated (66%).
For this study, 1768 out of 2757 invited men aged 65 to 87 years
were included from Tromsø 6 (67.7%). From BiAS, 509 out of 607
invited men aged 65 to 90 years were included (83.9%).
The Tromsø Study was approved by the Norwegian Data
Inspectorate and the Norwegian Directorate of Health. Both
studies were approved by the Regional Committees for Medical
and Health Research Ethics, and comply with the Declaration of
Helsinki. All participants gave informed written consent.
Assessment of atrial ﬁbrillation, physical activity and exercise
AF was assessed with the question “Do you have, or have you had
atrial ﬁbrillation?” in both studies.
In both studies, an identical question with a four-level scale was
used to assess LTPA: “How physically active have you been during
the past year in your leisure time. If your activity level varies
between summer and winter, note an average value. Tick one
only.” Levels of activity were deﬁned as follows: (a) sedentary
(reading, watching television, other sedentary activity); (b) light
PA (walking, cycling or other activity for at least 4 h per week); (c)
moderate PA (light sports, heavy gardening, for at least 4 h per
week); (d) high PA (regular hard exercise or competitive sports
several times per week). This scale was originally developed by
Saltin & Grimby (1968) and was used in middle-aged and elderly
Swedish athletes. It discriminates between sedentary persons and
their more active counterparts with respect to maximal oxygen
uptake (Saltin, 1977), and has been validated in the Tromsø popu-
lation (Emaus et al., 2010).
The participants in BiAS were asked for the total number of
years they had practiced systematic endurance training, the age
when they ﬁrst participated in theBirkebeiner race, howmany years
they had participated in the race, and howmanyBirkebeinermedals
they had won. Participants with a ﬁnishing time not exceeding 25%
of the average ﬁnishing time of the ﬁve fastest participants in each
5-year age class are awarded a Birkebeiner medal.
Assessment of health status and other characteristics
Age was registered at inclusion. Body mass index (BMI) was
calculated as weight (kg) divided by squared height (m). CHD was
assessed with the two questions “Have you had a heart attack?”
and “Do you have or have you had angina pectoris?” Hypertension
was assessed with the question “Do you take or have you ever
taken blood pressure lowering medicines?” Diabetes was assessed
with the question “Do you have diabetes?” Education level, health
status, smoking habits and alcohol consumption were assessed
with slightly different questions and categories, and recoded into
common categories. In Tromsø 6, height and weight were mea-
sured with subjects wearing light clothing and no shoes. Except
from height and weight in Tromsø 6, all variables were self-
reported by questionnaires, with only minor differences between
the studies. English translations are available on websites (http://
www.kavlisenter.no; http://www.tromsostudy.com).
Statistical analysis
Characteristics of the study populations were compared by Stu-
dent’s t-test for means of continuous variables and Pearson’s Chi-
square of independence for categorical variables.
A history of endurance sport practice, deﬁned as belonging to
the study population of skiers, was the main exposure. Total preva-
lence and prevalence after exclusion of persons with CHD were
reported for the variable self-reported AF outcome.
Both study populations were analyzed together in a linear
regression model with a robust variance estimator. The model
gives risk differences (RDs) with 95% conﬁdence intervals (CI)
for AF. When designing the model, a direct acyclic graph (DAG)
was used to identify covariates that are appropriate for adjustment.
The DAG shown in Figure 1 is simpliﬁed to aid readability.
Covariates and arrows not inﬂuencing the analysis are excluded.
The highlighted arrow represents the direct association between
endurance sport practice and AF. CHD, hypertension, diabetes,
age, height, BMI, education level, alcohol consumption, smoking
habits and LTPAwere adjusted for in the model. Health conscious-
ness in the DAG represents unmeasured confounding lifestyle
factors. In the variable “number of alcohol units usually consumed
when drinking,” there were over 10% missing data among the
skiers. Analysis after exclusion of cases with missing data for
alcohol consumption did not change the effect estimates.
Since odds ratios (ORs) are commonly reported for binary
outcomes like AF, we also report results from a logistic regression
model using the same covariates as the linear model.
All statistical analyses were conducted using SPSS version 20.0
(IBM, Armonk, NewYork, USA).
Results
Some characteristics of the study populations are shown
in Table 1. Participants in BiAS were on average 2.7
years younger, had a lower BMI, and were taller com-
pared with the general population. Higher proportions of
the skiers reported college or university education and
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current full-time employment. There were fewer
smokers and more alcohol consumers among the skiers.
They also reported higher levels of LTPA and valued
their own health as better than the general population in
Tromsø. All these differences were statistically signiﬁ-
cant.Among the skiers, the average BMI was normal and
the prevalence of traditional risk factors for AF was very
low. The crude prevalence of AF was 13.2% in the skiers
and 11.6% in the general population. The prevalence of
AF after exclusion of persons with CHD was 13.0% in
the skiers and 9.8% in the general population.
Figure 2 and Supporting Information Table S1 show
adjusted RDs with 95% CIs by selected covariates based
on the linear regression model. The constant term shown
in the ﬁrst line of the table describes the risk of AF for a
reference person, and was estimated to 11.3%. This
equals the expected prevalence ofAF when all covariates
are set at their reference values. Endurance sport practice
gave an added risk for AF of 6.0 percent points (pp)
(95% CI 0.8–11.1). The risk of AF increased with 0.4 pp
per added year of age. The risk of AF increased with 0.3
and 0.6 pp per cm of height and unit of BMI added,
respectively. Also hypertension and CHD were associ-
ated with added risk for AF. RDs were not signiﬁcant for
diabetes, smoking, lipid-lowering treatment or alcohol
consumption (Fig. 2).
Example
The estimated risk of AF for a sedentary 71-year-old man,
175 cm tall, with a BMI of 26.3, non-smoker with average
alcohol consumptionandeducation level, noCHD,diabetes
or hypertension and not practicing endurance sports was
11.3%. For a man with the same characteristics but who
practices endurance sports, the estimated risk was 13.0% if
reporting moderate PA (11.3+6.0−4.3%), and 17.6% if
reporting the highest level of PA (11.3+6.0+0.3%).
Associations expressed as relative effects (ORs) were
calculated by logistic regression. The adjusted OR (aOR)
for AF in men practicing sport was 1.28 (95% CI 0.94–
1.73) after adjustment for age and 1.90 (95% CI 1.14–
3.18) after multivariable adjustment for age, traditional
risk factors for AF and education. After exclusion of
persons with CHD and multivariable adjustment, the
aOR for AF was 1.81 (95% CI 1.04–3.14) (n = 1713).
Sensitivity analysis after exclusion of skiers who had
participated less than three times in the Birkebeiner race
did not change the effect estimates.
Discussion
This study suggests that elderly men with a history of
long-term endurance sport practice have a higher risk of
AF than elderly men in the general population. Light and
moderate LTPA during the previous year may reduce the
risk of AF, although this is not statistically signiﬁcant in
this study.
Our study conﬁrms earlier ﬁndings of a high preva-
lence of AF among elderly male long-distance cross-
country skiers (Grimsmo et al., 2010), and the
association between repeated participation in long-
distance cross-country ski races and increased risk ofAF,
recently discovered among Swedish skiers (Andersen
et al., 2013). Consistent with previous results from
Tromsø (Nyrnes et al., 2013), we did not ﬁnd an
increased risk of AF associated to level of LTPA. In
contrast, recently published results from a large
population-based study indicate that LTPA is associated
with an increased risk of AF in the middle-aged general
population (Thelle et al., 2013). The cohorts in these two
studies were younger than our study populations.
In accordance with previous studies, both body height
and BMI were positively associated with the risk of AF
(Mont et al., 2008; Nyrnes et al., 2013). The added risk
of AF per unit of BMI of 0.7 pp is similar to the OR of
1.08 for AF per unit of BMI found in a population-based
cohort of Danish men (Frost et al., 2005).
Study population
In the Cardiovascular Health Study of elderly people,
the most active people had the lowest incidence of
AF [hazard ratio (HR) 0.64, 95% CI 0.52–0.79]
(Mozaffarian et al., 2008) but they reported exercise cor-
responding to an average of only 1840 kilocalories per
week, which is probably much less than average in our
study population. Interestingly, exercise intensity was
associated with risk of AF in a U-shaped pattern: While
moderate intensity was associated with lower incidence
Fig. 1. Simpliﬁed direct acyclic graph (DAG). Arrows and
covariates not inﬂuencing the analysis are excluded. The high-
lighted arrow illustrates the direct association between sport
practice and atrial ﬁbrillation. The other arrows illustrate inter-
mediate covariates in the association (blue), confounding (red)
and colliding (violet) covariates.
(*) Endurance sport practice is covered by the term physical
activity. Due to different underlying mechanisms in the associa-
tion withAF, self-reported leisure time PAwas adjusted for when
estimating risk differences for AF.
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of AF, people reporting the highest intensity had the
same incidence as people not exercising. In The Physi-
cians Health Study, no association was found between
exercise frequency and risk of AF in physicians aged
50–84 years, although the most active doctors exercised
ﬁve to seven days per week (Aizer et al., 2009).
In our study, 61% of the skiers reported LTPA below
the highest level during the last 12 months. This might be
important in the interpretation of our results, as the
increased risk of AF associated with endurance sport
practice might partly be balanced by light or moderate
PA. This reduction in AF risk might be explained by a
reduced prevalence of AF risk factors, as demonstrated
in the DAG (Fig. 1).
The added risk of AF by long-term endurance sport
practice found in our study corresponds to an aOR of 1.90
(95% CI 1.14–3.18). Ameta-analysis reported an OR for
AF of 5.3 (95% CI 3.6–7.9) in athletes compared with
non-athletes (Abdulla & Nielsen, 2009). The higher ORs
reported in the meta-analysis and previous publications
(Karjalainen et al., 1998; Elosua et al., 2006; Molina
et al., 2008) might reﬂect exposure to sport practice at
higher levels than in our non-elite skiers, that different
types of endurance sports might be differently associated
to the risk of AF, or that the volume of training between
competitions varies between the study cohorts.
Control group
Even more importantly, the prevalence of AF in the
control groups inﬂuences the effect estimates strongly.
While the Finnish orienteering runners in Karjalainen
et al.’s study (1998) were compared with middle-aged
men with a low prevalence of AF, the skiers in our study
were compared with the general population with an AF
prevalence of 11.6%. The comparison of a highly
selected cohort of skiers with the general population
might be questioned. However, a control group of elderly
people with very low prevalence of traditional risk
factors for AF and without a history of endurance sport
practice might be difﬁcult to ﬁnd. In the study of
Swedish long-distance cross-country skiers, the HR for
AF among participants who had completed ﬁve or more
races was only 1.29 (95% CI 1.04–1.61), and no signiﬁ-
cant association was found between ﬁnishing time and
AF risk. The lack of comparison of the skiers with inac-
Table 1. Characteristics of participants of the Birkebeiner cross-country ski race and the general population in Tromsø, men 65–90 years old
Athletes
n = 509
General population
n = 1867*
Mean (median, range) Mean
Age 68.9 71.6
Height 178.5 174.3
Body mass index 23.6 27.0
Age at ﬁrst Birkebeiner race participation 43.6 (42, 18–76) –
Number of completed Birkebeiner races 17.0 (14, 1–53) –
Number of achieved Birkebeiner medals 11.5 (6, 0–49) –
Total years of systematic endurance training 33.2 (34, 1–67) –
% of 509 % of 1867
Live with a spouse or partner 88.2 79.1
College or university education 41.0 28.5
Occupation
Retired 60.9 86.1
Full-time work 37.9 9.1
Good or excellent self-reported health status 86.2 60.3
Self-reported leisure-time physical activity
Sedentary 0.2 19.4
Light 9.9 58.0
Moderate 50.9 21.9
High 39.0 0.7
Frequency of alcohol consumption
Never 9.6 14.2
1–4 times a month 72.6 64.0
2–3 times a week 14.7 15.6
4 or more times a week 3.1 6.2
Daily smoking
Current daily smoker 0.8 15.4
Previous daily smoker 28.5 60.6
Never smoked daily 70.7 24.0
Coronary heart disease 3.1 23.8
Diabetes 0.8 8.2
Current or previous lipid-lowering treatment 14.3 33.0
Current or previous antihypertensive treatment 14.9 39.0
*All P-values ≤ 0.001.
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tive people is discussed by the authors as an important
limitation of the study (Andersen et al., 2013).
Age
Age is another factor with an impact on effect estimates
and the younger age of the cohort of Swedish skiers
probably contributes to the weaker association. Long-
term PA and endurance sport practice reduces the risk of
CHD, hypertension and diabetes. These are all important
risk factors for AF and are increasingly prevalent with
increasing age. While the relative importance of other
modiﬁable risk factors decreases with increasing age, PA
is shown to be a robust health-promoting factor in
elderly people (Gulsvik et al., 2011). It is unclear how a
potentially stronger beneﬁcial effect of exercise in this
age group might inﬂuence the risk of AF. In the hetero-
geneous group of elderly, there might be both individuals
who beneﬁt from their history of endurance sport prac-
tice with reduced risk of AF and individuals who expe-
rience an increased risk due to age-related vulnerability
to strenuous endurance sport practice.
Strengths
The main strength of the study is the unique sample of
elderly and active long-distance cross-country skiers,
which on average has been exposed to endurance sport
practice over many years at a much higher level than the
general population. Previous studies of the association
between sport practice and risk of AF have been ques-
tioned (Delise et al., 2012) because many of the partici-
pants were exposed to cardiovascular risk factors like
smoking (Molina et al., 2008). The low prevalence of
traditional risk factors for AF in BiAS is another asset of
our study. Very few of the skiers were smokers, had CHD
or diabetes, and the prevalence of hypertension was
much lower than in the general population. Due to the
high response rate of almost 84%, we assume the study
population in BiAS to be representative for elderly men
participating in long-distance endurance competitions.
Finally, our results are strengthened by multivariable
adjustment for possible confounding from various life
style factors, health conditions and socioeconomic
status.
Limitations
The main limitation of the study is self-reporting of AF.
AF often remains unrecognized for a long time, espe-
cially in elderly people (Engdahl et al., 2013) and
because AF is often paroxysmal, the diagnosis might be
difﬁcult to conﬁrm. Palpitations and other symptoms
Fig. 2. Studied risk factors for atrial ﬁbrillation. Estimated atrial ﬁbrillation risk differences with 95% conﬁdence intervals by selected
covariates. Both study populations analyzed together, men 65–90 years old.
Myrstad et al.
e242
might be interpreted as AF, leading to false positive
reports. Thus, the validity and completeness of the
outcome measure is a weakness of many studies assess-
ing prevalence or risk of AF. The skiers might also be
more aware of heart rhythm disturbances than others and
more interested in participating in the study, which could
possibly lead to an overestimation of the risk of AF in
this population.
The cross-sectional design limits the possibility to
investigate causal associations, as it is unclear if the
outcome has preceded the exposure. However, in this
study it is unlikely thatAF has preceded the participation
in endurance sport, as most participants have practiced
long-distance cross-country skiing for many years.
Endurance sport practice was not recorded in Tromsø
6.We assume from the low number of participants report-
ing the highest levels of LTPAthat the number of subjects
participating in long-distance endurance competitions in
this study population is low or zero and that the difference
between the study populations could therefore be inter-
preted as binary. However, this could lead to an underes-
timation of the effect estimate in our study.
Elderly populations are heterogeneous and, despite
adjustment for chronological age, the degree of biologi-
cal ageing is likely to be differential between the study
populations, as expressed by differences in CHD and
cardiovascular risk factors. The study populations may
also differ in terms of unmeasured characteristics. In
population-based studies, the proportions of people with
ethnic minority background (Christensen et al., 2012)
and with poor health status (Knudsen et al., 2010) tend to
be larger among non-responders than among responders
and this trend tends to counteract selection bias in our
study. However, selection bias may have inﬂuenced our
results.
People without AF are more likely to continue partici-
pation in long-distance endurance sport competitions
into old age, corresponding to a healthy worker effect
(Thygesen et al., 2011). This assumption is supported by
the fact that there were no cases of AF among the skiers
aged 80 years and older and probably leads to an under-
estimated risk of AF among the skiers. On the contrary,
some skiers with AF might have been motivated to con-
tinue skiing because of the beneﬁcial effects of exercise.
Perspective
This study adds to the current knowledge regarding the
association between endurance sport practice and risk of
AF. In elderly men, a history of endurance sport practice
was found to be a risk factor for AF with an effect
comparable to traditional risk factors for AF like CHD
and hypertension. Light or moderate LTPA during the
last 12 months seems to partly balance the increased risk
of AF. It is still unclear if sport practice in different life
phases inﬂuences the risk of AF differentially and how
AF in this population of very active elderly men might
inﬂuence the risk of stroke. Regular PA reduces mortal-
ity, functional decline and the risk of several age-related
diseases. Elderly people should therefore be encouraged
to be physically active.
Key words: sports cardiology, arrhythmias, endurance
exercise, master athletes, elderly, cross-country skiing,
skiers, heart disease.
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Table S1 (supporting information): Estimated atrial fibrillation risk differences for endurance sport practice 
and other selected covariates. Both study populations analyzed together, men 65-90 years old.                       
Risk difference
%
95 % 
Confidence intervals
Constant term (*) 11.3
Level of self-reported leisure-time PA
Sedate 0 (ref)
Light - 3.7 (-8.4 – 0.9)
Moderate - 4.3 (-9.4 – 0.9)
High + 0.3 (-7.8 – 8.4)
Endurance sport practice +6.0 (0.8 – 11.1)
Age (per added  year) +0.4 (0.1 – 0.8)
Height (per added cm) +0.3 (0.1 – 0.6)
BMI (per added unit) +0.6 (0.1 – 1.0)
CHD + 4.9 (0.8 – 9.1)
Hypertension + 4.6 ( 1.1 – 8.1)
Diabetes +4.8 (-2.2 – 11.8)
(*) The constant term reported is the expected risk of AF for a 71-year old man, 175 cm tall and with a BMI of 
26.3, when sedate, not smoking, with an average alcohol consumption and level of education, no CHD, diabetes 
or hypertension and not practicing endurance sport. 
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Abstract
Background Atrial fibrillation (AF) is highly prevalent but has not previously been characterized in 
detail in veteran athletes. We aimed to describe physical activity (PA), symptoms, medication and 
subjective health in relation to AF subtype and co-morbidity among veteran cross-country skiers with 
AF.
Methods In total, 4952 Norwegian men and women aged 53-85 years took part in this 
cohort study, 2626 veteran cross-country skiers and 2326 from the general population. PA, endurance
exercise, functional capacity, co-morbidity, drug use and subjective health were self-reported by 
questionnaires. AF was self-reported and confirmed by electrocardiograms in a medical record review.
Results The prevalence of self-reported AF among veteran skiers was 12.3%. AF was 
confirmed in 140 skiers and 118 individuals from the general population. Among skiers with AF
(mean age 69 years), 52% had paroxysmal, 23% persistent and 24% permanent AF. AF was associated 
with poor subjective health, but 89% of the veteran skiers were physically active and 64% engaged in 
regular endurance exercise after the onset of AF. While 59% had experienced palpitations during the 
past year, 32% reported reduced functional capacity. Two out of three with AF and a CHA2DS2-VASc 
VFRUH used oral anticoagulants (OAC).
Conclusions AF was associated with poor subjective health, but the vast majority of veteran 
athletes engaged in regular PA and endurance exercise also after the onset of AF. This is important, as 
PA and exercise might reduce AF symptoms, mortality and morbidity. Many veteran skiers with AF 
were not optimally treated with OAC.
Abstract word count: 248
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Introduction and background
Atrial fibrillation (AF) is the most common clinically significant cardiac arrhythmia, and the 
prevalence is strongly related to age [1]. While uncommon at younger ages, the prevalence rises from 
1-4% at age 60 to >15% in populations aged >80 years [2,3]. In the short term, AF is associated with
symptoms, reduced physical capacity, drug use and poor subjective health [4,5]. In the long term, AF 
is associated with an increased risk of stroke and risk assessment using the CHA2DS2-VASc score has 
been recommended [1]. Individuals with AF and a CHA2DS2-VASc score VKRXOGbe treated with 
oral anticoagulants (OACs), but the adherence to such treatment is unsatisfactory [6,7].
While moderate physical activity (PA) reduces the risk of both AF and other cardiovascular 
diseases in older adults [8,9], AF is highly prevalent among veteran endurance athletes [10,11]. The
number of individuals aged >40 years that engage in endurance sports events is increasing [12,13], but 
AF has not previously been characterized in detail in veteran athletes. In individuals with AF, regular 
exercise might reduce symptoms and improve functional capacity [14]. Thus, engagement in PA after 
onset of AF is crucial, both in the short term and in order to profit from the universal long-term 
benefits of regular exercise [15]. We are not aware of any studies that have addressed PA and exercise 
among veteran athletes with AF.
AF symptoms might be due to the arrhythmia or due to co-morbidity and symptoms vary 
between different AF subtypes. Few studies have differentiated between paroxysmal, persistent and 
permanent AF or between AF with and without co-morbid conditions [5].
We aimed to describe PA, functional capacity, palpitations, medication and subjective health
related to AF subtypes and co-morbidity among Norwegian veteran cross-country skiers, and to 
compare veteran athletes and individuals from the general population with AF.
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Methods
Study populations
All 3,485 individuals who ZHUHDJHG\HDUVDQGparticipated in the Birkebeiner cross-country ski 
race in 1999, and had a Norwegian postal address, were invited to participate in this cohort study.
Cross-country skiing has been classified as a highly dynamic sport with moderate to high 
cardiovascular demand during competition [16], and the 54-kilometre Birkebeiner race is among the 
world’s most challenging cross-country ski-races.
Meanwhile, 4,015 men and women who had previously taken part in the population-based 
Oslo Health Study in 2000-01 and 2009 DQGZHUHDJHG\HDUVLQwere also invited to 
participate. A flow chart describing the inclusion process is shown in the supplementary figure 1.
During 2012, both the veteran skiers and the participants from the Oslo Health Study received 
an identical postal questionnaire (supplementary data) together with an invitation letter.
The study was approved by the Regional Committee for Medical and Health Research Ethics 
and complies with the Declaration of Helsinki. Approvals for the review of the medical records were 
obtained from the responsible authorities for research and data protection for each hospital.
Atrial fibrillation and co-morbid conditions
Self-reported AF was defined by positive response to at least one of the two questions “Do you believe 
that you have or have had atrial fibrillation?” or “Have you been diagnosed as suffering from atrial 
fibrillation by a doctor?” in the questionnaire. Co-morbid conditions (myocardial infarct, angina 
pectoris, coronary bypass, cardiac valve replacement, stroke, diabetes mellitus, hyperthyroidism) were 
assessed with the question “Do you have or have you ever had (name of disease)?” Concomitant heart 
diseases were condensed into one variable. CHA2DS2-VASc score was estimated using age, sex and 
self-reported coronary heart disease, hypertension, stroke and diabetes mellitus.
During 2013 medical records were reviewed in subjects who reported AF, gave consent and 
named a Norwegian public hospital where they were diagnosed. Incident arrhythmias up until 
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31.12.2012 were identified by electrocardiograms (ECGs). Atrial flutter was not assessed in the 
questionnaire, and because of the close interrelationship between AF and atrial flutter, both 
arrhythmias were classified together as AF. The following subtypes of AF were self-reported and 
supplemented with data from the medical records: Paroxysmal (attacks that end by themselves or with 
medical treatment), persistent AF (attacks that are only alleviated by intravenous treatment or electric 
shock) and permanent (AF the entire time). Paroxysmal and persistent were classified together as non-
permanent AF. If the review did not reveal other relevant concomitant conditions (heart disease, 
diabetes, hyperthyroidism, acute infection, surgery during the past seven days), the arrhythmia was 
classified as AF without co-morbidity. In individuals with hypertension the arrhythmia was classified 
as without co-morbidity if echocardiography findings were available and normal.
Physical activity and exercise
Leisure-time PA during the past year was assessed with the question “State the movement and PA you 
engage in during your leisure time. If your activity level varies between summer and winter, note an 
average value. Tick the most appropriate box only”. A five-level scale was condensed into the four 
categories: 1) Sedentary (reading, watching television, other sedentary activity); 2) Light PA (walking, 
cycling or other activity for at least 2 hours per week); 3) Moderate PA (light sports, heavy gardening, 
for at least 4 hours per week); and 4) High PA (Regular hard exercise or competitive sports several 
times per week). This scale was originally used among middle-aged and elderly Swedish athletes in 
the 1960’s [17], and is validated among Norwegian men [18,19]. The participants were asked if they 
still engaged in regular endurance exercise, defined in the questionnaire DVH[HUFLVHERXWVRI
PLQXWHVWKUHHWLPHVSHUZHHNZLWKWKHJRDORILPSURYLQJHQGXUDQFHFDSDFLW\7KH\ZHUHDOVRDVNHG
to report if they were still participating in the Birkebeiner race, and to give the reason for no longer
participating in the race. 
Functional capacity, palpitations, medication and subjective health
Functional capacity was assessed with the New York Heart Association (NYHA) functional 
classification (class I-IV) [20]. The participants were asked to report how their heart disease impact on 
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their functional capacity with four answer categories; I) No limitations. Ordinary PA does not cause 
undue fatigue, dyspnea or chest pain; II) Slight limitations of PA, but comfortable at rest. Ordinary PA 
results in fatigue, dyspnea or chest pain; III) Marked limitations of PA, but comfortable at rest. Even 
light PA causes fatigue, dyspnea or chest pain; and IV) Inability to carry on any PA without 
discomfort. Fatigue or chest pain may be present even at rest.  The NYHA classification was originally 
developed for use in heart failure patients, but has also been used in AF patients in different settings 
and is a valid measure of functional capacity [5]. The NYHA-classes were condensed into the two 
categories “no functional limitations” (class I) and “functional limitations” (class II-IV). 
Palpitations were assessed with the question “Have you noticed sudden changes in your heart 
rate or heart rhythm in the past year?” This question was used in the Tromsø Study, a population-
based health study in the largest city of northern Norway [21]. Other AF symptoms were not assessed. 
The participants reported use of the following medicines: Beta-blockers, calcium-channel-
blockers, amiodarone, dronedarone, flecainide, digitoxin, digoxin, acetylsalisylic acid (ASA), warfarin 
and dabigatran.
Subjective health was assessed with the question “How do you rate your own health?” and the 
four answer categories were condensed into poor (response to poor or fair) and good (response to good 
or excellent) health. The question has been used previously in AF patients [4], is a reliable and valid 
measure of subjective overall health status, including biological, psychological and social dimensions 
of health, and is associated with morbidity and mortality [22,23].
Statistical analysis
All study participants ageG\HDUVZHUHLQFOXGHGLQWKLVDQDO\VLV. We used Student’s t-test for 
means of continuous variables and Pearson’s Chi square of independence for categorical variables to 
compare characteristics of the study participants. Individuals with missing data in the variable 
functional capacity (24%) were categorized into NYHA class I. Multivariable logistic regression 
analysis was used to calculate adjusted odds ratios (aORs) with 95% confidence intervals (CI) for poor 
subjective health Adjustments were made for age, sex, body mass index (BMI), concomitant heart 
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disease, diabetes mellitus, stroke and number of completed Birkebeiner races. All statistical analyses 
were conducted using SPSS version 20.0 (IBM, Armonk, NewYork, USA).
Results
After exclusion of 27 individuals aged >85 years, 2626 veteran cross-country skiers (76% of the 
invited) were eligible for the analyses. AF was reported by 322 (12.3%), medical records were 
available for review for 177 and AF was confirmed in 140 skiers. Among 2326 participants from the 
general population, there were 260 cases of self-reported AF of whom 118 were confirmed and 
included in this analysis. Among veteran skiers, 52% had paroxysmal, 23% had persistent and 24%
had permanent AF, while the corresponding proportions in the general population were 52%, 17% and 
30%.
Table 1 shows the characteristics of veteran skiers without AF, with confirmed AF, with self-
reported but not confirmed AF and individuals with AF from the general population. Skiers with 
confirmed AF were older and had a higher prevalence comorbid conditions than skiers without AF.
The prevalence of stroke was more than twice as high in skiers with AF compared to skiers without 
AF. Skiers with AF were slightly younger, had lower BMI and less co-morbidity than their 
counterparts from the general population. There were only two women with AF among the skiers.
Only 11% of the veteran skiers with AF were inactive, 70% reported moderate or high PA 
during the past year and 64% still engaged in regular endurance exercise at least three times per week. 
However, a third of the veteran skiers with AF had discontinued their participation in the Birkebeiner 
race due to the arrhythmia and AF was associated with poor subjective health after adjustment for age, 
sex, BMI, co-morbid conditions and number of completed Birkebeiner races (aOR of 2.8 (CI 1.7-4.6)).
The corresponding estimate for AF without co-morbidity was 1.9 (CI 0.9-3.9).
Palpitations during the past year were reported by 59% of the veteran skiers and 68% in the 
general AF population. Reduced functional capacity (NYHA II-IV) was prevalent in 32% and 33%,
respectively. Poor subjective health was less common in skiers with AF compared to individuals with 
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AF in the general population (18% versus 31%), but did not differ after multivariable adjustment (data 
not shown). Veteran skiers were more active and used less rate-controlling drugs (43% vs. 73%). 
Table 2 shows PA, functional capacity, palpitations, AF medication and subjective health according to 
subtype of AF in skiers and the general population. Skiers with permanent AF were less active than 
skiers with non-permanent AF, while there was no difference in PA between the AF subtypes in the 
general population.  Palpitations, functional capacity, medication and subjective health did not differ 
significantly between the AF subtypes.
Out of 62 veteran skiers with AF and an estimated CHA2DS2-VASc score 41 (66%) used 
OAC, 9 (15%) used ASA and 12 (19%) were untreated.  In the general AF population, 54 out of 86 
with an estimated CHA2DS2-9$6FVFRUHXVHG2$&DQGXVHG$6$The 
proportion treated with OAC was highest in permanent AF (87%) and lowest in paroxysmal AF 
(51%). 
In the review of medical records, 57% of the veteran skiers and 42% in the general population 
were classified as AF without co-morbid conditions. Table 3 shows characteristics according to co-
morbidity. Individuals with AF without co-morbid conditions were more physically active and 
reported better subjective health than those with co-morbidity. Palpitations, functional capacity and 
use of rate-controlling drugs did not differ between the two groups.
Characteristics and triggers of AF attacks in veteran skiers and the general population with 
non-permanent AF (n=184) are shown in the supplementary table 1. Palpitations during the past year 
and frequency of AF attacks did not differ between the two groups. Among the veteran skiers,
paroxysms were triggered by exercise in 25% and often occurred in relation to typical vagal triggers.
Discussion
In this study we have described AF in detail in veteran athletes and demonstrated that the vast 
majority engaged in regular PA and endurance exercise even after the onset of AF. 
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AF was highly prevalent among the veteran athletes in this study [24]. This is in line with 
results from previous studies of Norwegian cross-country skiers [10,11], and supports that endurance 
sport practice might be associated with an increased risk of AF [25,26].
More than 50% of the skiers with AF experienced palpitations during the past year and one out 
of three reported reduced functional capacity. Palpitations have been reported to occur more frequently 
in athletes with AF than in general AF populations [27], but did not differ between the AF 
subpopulations in our study. In both groups, symptoms were less frequent than in previous studies
[28,29]. This might be explained by differences in the distribution of AF subtypes and co-morbidity 
between studies. In this study, palpitations and functional capacity reduction did not differ between the 
AF groups with and without co-morbid conditions. On the other hand, poor subjective health was 
more common in individuals with co-morbidity. A previous study suggested that AF is well tolerated 
in athletes [30], and our result might support that subjective health depends on comorbid conditions
among veteran athletes with AF.
Two out of three with an estimated CHA2DS2-9$6FVFRUH used OAC. Although self-
reports might provide imprecise information on adherence to OAC treatment and the stroke risk score 
is roughly estimated in this study [31], this result indicates that one out of three is not optimally 
treated. Only 3% used dabigatran, while the remaining 97% used warfarin. Dabigatran was introduced 
first and was the only among the novel oral anticoagulants (NOACs) that was investigated in this 
study. None of the NOACs were used routinely in Norway at the time of this study [32].
The proportion using rate-controlling drugs was lower among the skiers compared to the 
general AF population in our study, but higher than in the ALFA study conducted in France during the 
1990’s [33]. This might reflect differences in AF medication prescription between countries and over 
time. Our clinical experience is that endurance-trained individuals often have lower heart rates without 
medication, and that active individuals often refuse to use beta-blockers due to side effects. 
In the general population, stress was the most commonly reported trigger for AF attacks. This 
is in line with results from a previous study among 100 Swedish AF patients seeking hospital 
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assistance [34]. Vagal triggers were more common in veteran skiers, reflecting different underlying 
mechanisms of AF [26,35,36].
Limitations
Because AF might be asymptomatic and is impossible to detect between attacks in individuals with 
paroxysmal AF, the prevalence of AF might be underestimated in our study. On the other hand, AF is 
often asymptomatic [1], and because AF was confirmed in hospital, symptoms are likely to be 
overestimated among the athletes with confirmed AF. The validity and reliability of self-reporting of 
AF symptoms and subjective health are unknown, but in general, athletes might be more prone to 
report symptoms than others. Other symptoms than palpitations were not assessed and established 
scoring systems for AF symptoms were not used in this study [5]. Cardioversion and ablation might 
influence both symptoms, PA and the use rate-controlling drugs and OAC [37], but these treatments 
were not investigated in this study. The direct comparison between the two AF subpopulations in the 
study is hampered by the low number of women with AF and lower proportion with permanent AF 
among the skiers. The underlying mechanisms for AF are likely to differ between the subpopulations
[26], as indicated by a higher proportion with AF in absence of co-morbid conditions and typical vagal 
triggers for AF paroxysms among the skiers.
Strengths 
The population of veteran athletes exposed to prolonged endurance exercise is a main strength of this 
study. This, in addition to the validation of AF diagnoses by review of medical records, the 
differentiation between AF subtypes and the collection of data on co-morbid conditions, enabled a 
detailed characterization of AF in a growing subpopulation, namely older individuals exposed to 
prolonged endurance exercise with low co-morbidity but increased risk of AF. Although the study 
population of veteran athletes is selected, the high response rate of 76 % is another asset of this study
and we believe that our results might be generalizable to other populations of veteran athletes who 
have been performing at a high competitive level with prolonged endurance exercise [36].
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The design of this study does not allow conclusions regarding beneficial effects of exercise, 
and further studies should address whether veteran athletes with AF might also benefit from regular 
exercise in terms of reduced symptom burden, improved exercise capacity, decreased heart rate, 
improved heart rate variability and increased quality of life [38,39]. It remains unclear whether the 
stroke risk in veteran athletes with AF is comparable to that of general AF populations. Until the long-
term consequences of AF in this part of the population has been investigated in prospective studies, 
veteran athletes with AF should be treated in line with current guidelines [1].
Conclusions
AF was associated with poor subjective health among veteran athletes with AF, but the vast majority 
of veteran athletes still engaged in regular PA and endurance exercise after onset of AF. This is 
important, as PA and exercise might reduce AF symptoms, and in the long term probably reduce 
mortality and morbidity. Many veteran athletes with AF were not optimally treated with OAC in order 
to prevent stroke.
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Table 1: Characteristics of the study populations. Men and women aged 53-85, n=2747.
Veteran skiers 
without AF
n=2304
Veteran skiers with 
confirmed AF
n=140
Veteran skiers with 
self-reported AF
n=185
General population 
with AF
n=118
Mean (median, range) Mean (median, range) Mean (median, range) Mean (median, range)
Age (years) 64.0 (63, 53-85) 68.5 (69, 53-85) 64.9 (65, 53-85) 69.8 (71, 56-73)
Body mass index (kg/m2) 24.1 (23.9, 14.4-40.0) 24.4 (24.2, 19.9-32.4) 24.5 (24.0, 19.4-35.2) 26.2 (25.8, 18.8-43.2)
Education (years) 14.1 (15, 0-30) 13.9 (15, 0-24) 14.2 (15, 0-26) 14.6 (15, 0-31)
Completed Birkebeiner races 13.8 (12, 1-57) 17.3 (15, 1-49) 14.3 (13, 1-45) -
n (% of 2304) n (% of 140) n (% of 185) n (% of 118)
Females 274 (12%) 2 (1%) 7 (4%) 35 (30%)
Stroke 89 (4%) 14 (10%) 8 (4%) 14 (12%)
Concomitant heart disease 153 (7%) 24 (19%) 16 (9%) 32 (27%)
Antihypertensive treatmenta 498 (22%) 61 (44%) 51 (28%) 71 (60%)
Diabetes mellitus 86 (4%) 7 (5%) 6 (3%) 14 (12%)
Lipid-lowering treatment* 573 (25%) 51 (36%) 55 (30%) 50 (42%)
CHA2DS2-VASc score  - 62 (44%) 57 (31%) 86 (73%)
Oral anticoagulation therapy - 63 (45%) 31 (17%) 70 (59%)
Acetylsalicylic acid - 27 (19%) 28 (15%) 25 (21%)
Daily smoking b 45 (2%) 1 (1%) 0 (0%) 10 (9%)
Frequency of alcohol intakeb
<once per month 282 (12%) 18 (13%) 26 (14%) 15 (13%)
>once per week 847 (38%) 50 (36%) 67 (36%) 63 (53%)
Leisure-time physical activity
Sedate 222 (10%) 16 (11%) 20 (11%) 47 (40%)
Light 369 (16%) 26 (19%) 21 (11%) 48 (41%)
Moderate 1209 (53%) 75 (54%) 100 (54%) 22 (19%)
High 504 (22%) 23 (16%) 44 (24%) 1 (1%)
Engaged in 
regular exercisec
1682 (73%) 90 (64%) 134 (72%) 26 (39%)
Still participating 776 (34%) 27 (19%) 52 (28%) -
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in the raced
Reason for not 
participatingd
Atrial fibrillation - 50 (36%) 34 (18%) -
Other disease 139 (6%) 8 (6%) 10 (5%) -
Not motivated 657 (29%) 27 (19%) 42 (23%) -
Reduced physical capacity 93 (4%) 11 (8%) 12 (6%) -
Others 627 (27%) 17 (12%) 37 (20%) -
Poor subjective health 128 (6%) 25 (18%) 24 (13%) 35 (31%)
AF = Atrial fibrillation. 
a Current. b During the previous 12 months. c 6WLOOHQJDJHGLQUHJXODUHQGXUDQFHH[HUFLVHERXWVRIPLQXWHV
WLPHVSHUZHHNZLWKWKHJRDOWRLPSURYHRUPDLQWDLQHQGXUDQFHFDSDFLW\
d Participating in the annually 54-kilometre Birkebeiner cross-country ski race.
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Table 2: Physical activity, palpitations, functional capacity, use of rate-controlling drugs and subjective 
health according to atrial fibrillation subtype in veteran skiers and the general population aged 53-85
years,=253.
AF = Atrial fibrillation. 
a Moderate or high levels of leisure-time physical activity during the past year. b During the past year. 
c New York Heart Association class II-IV. d Drugs taken daily.
Veteran skiers with AF (n=137) General population with AF (n=116)
Non-
permanent
Permanent p-value Non-
permanent
Permanent p-value
n=104
(%)
n=33
(%)
n=77
(%)
n=34
(%)
Physical activitya 78 (75%) 18 (55%) <0.05 15 (19%) 7 (19%) 0.93
Palpitationsb 65 (63%) 15 (46%) 0.09 57 (71%) 22 (61%) 0.28
Reduced capacityc 30 (29%) 14 (47%) 0.47 22 (28%) 16 (44%) 0.07
Rate-controlling drugsd 43 (43%) 15 (47%) 0.67 53 (70%) 28 (78%) 0.37
Poor subjective health 16 (16%) 8 (25%) 0.23 25 (33%) 9 (27%) 0.53
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Table 3: Physical activity, palpitations, functional capacity, use of rate-controlling drugs and subjective 
health in individuals with atrial fibrillation according to co-morbid conditions. Men and women aged 53-
85 years, n=258.
Atrial fibrillation without co-
morbid conditions
n=130
(80 veteran skiers) 
(%) 
Atrial fibrillation with 
comorbid conditionse
n= 128
(60 veteran skiers)
(%) 
p-value
Physical activitya 69 (53%) 52 (41%) <0.05
Palpitationsb 85 (65%) 77 (60%) 0.39
Reduced capacityc 38 (29%) 46 (36%) 0.25
Rate-controlling drugsd 72 (58%) 69 (55%) 0.70
Poor subjective health 22 (18%) 38 (31%) <0.05
Veteran skiers and individuals from the general population analyzed together. a Moderate or high levels of 
leisure-time physical activity during the past year. b During the past year. c New York Heart Association class II-
IV. d Drugs taken daily. e Heart disease, diabetes, hyperthyroidism, acute infection or surgery during the past
seven days (registered during the review of medical records). In individuals with hypertension the arrhythmia 
was classified as without co-morbidity if echocardiography findings were available and normal.
19 
Cohort 1: All individuals who 
participated in the Birkebeiner
cross-country ski race in 1999, 
had a Norwegian postal adress
and were born before 1960.
n = 3485
Cohort 2: All individuals born 
before 1960 participating in 
the second survey (2009) of 
the population-based Oslo 
Health Study.
n = 6995
3000 randomly selected 
among 5982
individuals who did not 
report any heart rhythm 
disturbances in the 
second survey of The 
Oslo Health Study.
n = 3000
All individuals who 
reported to have or 
have had an heart 
rhythm disturbances in 
the second survey of 
The Oslo Health 
Study.
n = 1013
Non-responders
n = 832
Non-responders
n = 348
Non-responders
n = 930
Eligible for 
inclusion
n = 2626
Eligible for 
inclusion
n = 500
Eligible for 
inclusion
n = 1826
Self-reported atrial fibrillation
n = 322 ( prevalence 12.3%)
Self-reported atrial fibrillation
n = 260
Skiers with confirmed
atrial fibrillation
n = 140
Confirmed atrial fibrillation
(general populaton)
n = 118
Aged >85
n = 27
Aged >85
n = 244
Aged >85
n = 167
Supplementary figure 1: Inclusion process in the Birkebeiner Atrial Fibrillation Study
 
 
 
 
 
 
 
 
 
 
 
Appendices  

1 
ID number: . ……..       Date………… 
The Birkebeiner Ageing Study (BiAS) - questionnaire
Part 1: 
Age ……….. 
Gender  
Male 
 Female 
Weight and height  
Weight (kg)……..
Height (cm)……
How many times have you completed the Birkebeiner cross country ski race? ……… 
How many times have you been awarded with the Birkebeiner Medal? ……….. 
How old were you when you first attended? ……….. 
Do you participate in other skiing events?  
 Yes  
 No
Do you participate in other bike competitions, cross country running race or street race? 
 Yes  
 No 
At what age did you start with systematic training for the Birkebeiner cross country ski 
race (or other competitions)? ………... 
Have you had any interruption in training (more than 3 months) due to illness? 
 Yes   
 No  
Have you ever been prevented from participating in the Birkebeiner cross country ski 
race due to illness? 
 Yes     
 No    
What was the reason? ………………………………………………………………………………..
Do you have, or have you had atrial fibrillation (attack with rapid irregular heartbeat)? 
 Yes, once  
 Yes, several times        
 Yes, I have a chronic condition      
 No                             
2 
Do you find that participation in Birkebeiner cross country ski race and the training it 
takes to affect your quality of life (well-being)? 
 For the better   
 Has little impact  
 For the worse   
 Do not know    
Do you feel that participating in the Birkebeiner cross country ski race and the training 
it takes to affect the ageing process?
Makes me feel younger than my peers  
Makes no difference     
Makes me feel older than my peers  
 Do not know       
If you look back at your life, what sport and what exercises did you start with? 
………………………………………………………………………………………………… 
How old were you when you started with endurance training? 
………………year
Part 2.  CONOR- Health questionners  YOUR OWN HEALTH
     
1. What is your current health status? Tick one only
 Poor   
 Not so good  
 Good  
 Very good  
2. Do you have, or have you had? 
   Yes    No Age first time 
Heart attack    
Angina pectoris (heart cramp)    
Cerebral stroke/ Brain haemorrhage    
Asthma    
Diabetes    
3. Have you during the last year suffered from pain and/or stiffness in muscles and 
joints that have lasted for at least 3 months ? 
 Yes   No 
4. Have you in the last two weeks felt : 
 No A little A lot Very much 
Nervous or worried     
Anxious     
Confident and calm     
Irritable     
Happy/Optimistic     
Down/Depressed     
Lonely     
   
3 
PHYSICAL ACTIVITY 
5a. How has your physical activity during leisure time been over the last year ? Think of 
your weekly average for the year. Time spent going to or from work counts as leisure time 
Hours per week    None Less than 1 1-2 3 or more 
Light activity (not sweating or out of 
breath)
    
Hard physical activity (sweating/out of 
breath) 
    
5 b. Please note physical activity during the past year in your leisure time. If your 
activity level varies between summer and winter, note an average value.   
(Tick one only)
  Reading, watching TV or any other sedentary activity?    
 Walking, cycling, or other activity, other for at least 4 hours a week? 
(Count also walking back and forth from work)  
 Light sports, heavy gardening? 
(At least 4 hours per week)      
 Hard exercise, competitive sports? Regularly and several times a week  
SMOKING 
6 . How many hours a day do you normally spend in smoke-filled rooms? Write 0 if you 
don`t spend time in smoke-filled rooms
Number of hours ……….. 
7. Did any of the adults smoke at home when you grew up? 
 Yes     No 
8. Do you now, or have you ever lived together with a daily smoker after the age of 20 
years? 
 Yes  No 
9. Do you smoke ? 
 Yes No 
Cigarettes daily   
Cigars/cigarillos daily   
Pipe daily   
  
10. If you previously smoked daily, how long is it since you quit? …… number of years 
11. If you smoke daily now or previously: How many cigarettes do you, or did you 
usually smoke per day?    Number of cigarettes ……… 
12. How old were you when you began smoking? …….. year 
13. How many years in all have you smoked daily ? …….. years 
COFFEE, TEA AND ALCOHOL 
14.a How many cups of  coffee do you usually drink daily ? 
Write 0 if you do not drink coffee daily  
Boiled coffee (coarsely ground), number……  
4 
Coffee other, number……….. 
14.b  
What type of coffee do you usually drink? Please tick 
 Filter/instant coffee    
 Boiled coffee (coarsely ground)    
 Other (espresso etc)  
 Do not drink coffee     
How many cups of  coffee/tea do you usually drink daily? Write 0 if you do not drink 
coffee/tea daily  
Number of cups with coffee………….  
Number of cups with tea………… 
15 a. How many times a month do you usually drink alcohol? Do not count low-alcohol 
beer. Put 0 if less than once a month.  
Number of times…………. 
15 b. Approximately how often during the past 12 months have you consumed alcohol? 
(Do not count low-alcohol beer) 
 4-7 times a week    2-3 times a month  Have not drunk alcohol the last year    
 2-3 times a week     Appr. 1 time a month   Have never drunk alcohol 
 App. 1 time a week A few times last year    
  
16 a. How many glasses of beer, wine or spirits do you usually drink during a two-weeks 
period? Do not count low-alcohol beer. Put 0 if you do not drink alcohol.
Beer ……. glasses   Wine ……glasses   Spirits …….glasses 
For those who have consumed alcohol during the  past year  
16 b. When you drank alcohol, how many glasses did you usually drink ?  
Number of glasses…………. 
16 c. Approximately how often during the past 12 months have you consumed alcohol
corresponding to at least 5 glasses of spirits in 24 hours?  
Number of times……….. 
16 d. When you drink alcohol, do you usually drink: (Tick one or more).
 Beer Wine  Spirits (hard liquor) 
16. Are you a total abstainer from alcohol?
Yes  No 
EDUCATION 
17 a. What is the highest level of education you have completed? 
 Less than 7 year of primary school  
 7-10 years primary/secondary school  
 Technical school, middle school, vocational school, 1-2 years senior high school  
5 
 High school diploma (3-4 years)  
 College/university, less than 4 years  
 College/university, 4 or more years 
17 b. How many years education have you completed all together?
(Count every year you went to school) Number of years………….
ILLNESS IN THE FAMILY 
18. Have one or more of your parents or siblings had a heart attack or angina pectoris?
 Yes      No  Don't know 
19. Tick for those relatives who have or have had: 
  
 Myself  Mot
her 
Fat
her 
Brot
her 
Sister Chil
d 
Cerebral stroke or brain 
haemorrhage 
      
Myocardial infarction before 
age 60 
      
Asthma       
Cancer       
Diabetes       
Age when diabetes was first 
diagnosed 
      
  
RESIDENLY 
20. In which muncipality did you live at the age of 1 year? If you did not live in Norway, 
give country of residence instead of municipality. ……………………….. 
21. What type of dwelling do you live in? 
 Villa/detached house  
 Farm  
 Flat/apartment  
 Terraced/semi-detached house  
 Other/institution/care home 
22. How large is your home? ………m2 
FAMILY AND FRIENDS 
25. With whom do you live? Tick one for each question and write the number
 Yes No Number
Spouse/Partner  
Other persons older than 
18 years 
  
Persons younger than 18 
years 
  
27. How many good friends do you have with whom you can talk confidentially and who 
can provide help if you need it?
(Do not count people you live with, but do include other relatives)  
6 
…………… 
28. Do you feel that you have enough good friends? 
 Yes   No 
29. How often do you usually take part in organised activities, e.g. sewing circles, sports 
clubs, political meetings, religious or other organizations? 
 Never, or just a few times a year 
 1-3 times a month 
 Approximately once a week 
 More than once a week 
WORK 
30. What is your current work situation? 
 Paid work 
 Full-time housework 
 Under education, military service 
 Unemployed, on leave without payment 
 Pensioner 
31 a. How many hours of paid work do you have per week? ……….number of hours 
31 b. What is your current work situation – paid work? 
 Yes, full-time 
 Yes, part time  
 No 
32. Do you receive any of the following?  
 Sickness benefit? 
 Old-age pension? 
 Rehabilitation benefit? 
 Disability pension? 
 Unemployment benefits? 
 Social welfare benefits? 
 Social benefit-single parent? 
33. Do you work shifts or nights?
 Yes   No 
34. If you have paid or unpaid work, which statement describes your work best?  
 Mostly sedentary work? (e.g. office work, mounting) 
 Work that requires a lot of walking? (e.g. shop assistant, light industrial work, teaching) 
 Work that requires a lot of walking and lifting? (e.g. postman, nursing, construction) 
 Heavy manual labour? (e.g. forestry, heavy farmwork, heavy construction)
7 
35. Do you decide yourself  how your work will be done? (Tick one only)  
 Not at all 
 Very little 
 Yes, sometimes 
 Yes, my own decision 
36 a. Do you have any of the following occupations ? (full time or part time) Tick one for 
each question 
 Yes No 
Driver   
Farmer   
Fisherman   
36 b. What occupation/title did you have at this work? Ex secretary, teacher, industrial 
worker, nursing, carpenter, leader, salesman, driver etc)
Occupation:……………………………………………… 
YOUR OWN ILLNESS and INJURIES 
37. Have you ever had:
Tick one for each question. State age at event. If it has happened several times, write age at 
the last event. 
Ye
s 
No Age at last time 
Hip fracture    
Wrist/forearm fracture    
Whiplash    
Injury requiring hospital admission    
38. Do you have or have you ever had? 
Tick yes or no for each question
Yes No 
Hay fever   
Chronic bronchitis/emphysema   
Osteoporosis   
Fibromyalgia/fibrositis/chronic pain syndrome   
Psychological problems for which you have sought help   
   
39. Do you cough almost daily for some periods of the year? 
 Yes   No 
40. If yes,
do you bring up phlegm?  
 Yes   No 
41. If you cough almost daily for some periods of the year, have you had this kind of 
cough for as long as 3 months in each of the last two years? 
 Yes   No 
42. How often do you suffer from sleeplessness? 
8 
 Never, or just a few times a year 
 1-3 times a month 
 Approximately once a week 
 More than once a week 
43. Have you in the last twelve months suffered from sleeplessness to the extent that it 
has affected your ability to work ? 
 Yes   No 
USE OF MEDICATION 
44 . Do you take?   
 Currently Previously Never 
Lipid lowering drugs    
Medications for high blood 
pressure 
   
              
45 a. Have you for any length of time in the past year used any of the following 
medications every day or almost daily? Indicate how many months you have used the 
medication. Write 0 if you did not take the medication.
Medications:      
Painkillers   ……… months. 
Sleeping pills   ……… months. 
Tranquilizers   ……… months. 
Antidepressants  ……… months. 
Allergy pills   ……… months. 
Asthma medication  ……… months. 
Only medication bought at pharmacy. Do not include dietary supplements. 
45 b. How often during the last 4 weeks have you taken any of the following medication? 
Tick one per line          
Daily 
Weekly but not 
daily 
Less than
weekly 
Not taken last 4 
weeks 
Painkillers without 
prescription 
    
Painkillers on prescription     
Sleeping pills     
Tranquilizers     
Antidepressants     
Other medication on 
prescription 
    
DIETARY SUPPLEMENTS 
46 a. Have you for any length of time in the past year taken any of the following daily or 
almost daily? Indicate how many months you have used them. Write 0 if you did not take any. 
Iron tablets   ……….. months 
Vitamin D supplements ……….. months 
Other vitamin supplements ……….. months 
9 
Cod liver oil   ……….. months 
46 b. Do you take any of the following? 
  
Yes, daily Sometimes No 
Cod liver oil, capsules, Fish oil capsules    
Vitamin and or mineral supplements    
THE REST OF THE FORM SHOULD ONLY BE FILLED IN BY WOMEN
47. How old were you when you started menstruating?
………..year 
48. If you no longer menstruate, how old were you when you stopped menstruating? 
………..year 
50. How many children have you given birth to? 
………children 
51. If you have given birth, what year was the child born and how many months did you 
breastfeed each child 
Child Year born   Number of months with 
breastfeeding 
1.   
2.   
3.   
4.   
5.   
6.   
52. Do you use or have you ever used: 
Now Previously Never 
Contraceptive pills (OC) (incl. minipill)    
Contraceptive injections    
Hormonal intrauterine device    
Estrogen (tablets or patches)    
Estrogen (cream or suppositories)    
  
10 
International Physical Activity Questionnaire (IPAQ)
The questions will ask you about the time you spent being physically active in the last 7 days.  
                                                                        Activity Level 
Remember: Think only about those physical activities that you did for at least 10 minutes at a time.  
1a: During the last 7 days, on how many days did you do 
vigorous physical activities like heavy lifting, digging, 
aerobics, or fast bicycling,? 
Think about only those physical activities that you did for at 
least 10 minutes at a time. 
…………days per week None 
(Skip to 
question 2a) 
1b: How much time in total did you usually spend on one of 
those days doing vigorous physical activities? ………………..hours 
………………minutes 
2a: Again, think only about those physical activities that you 
did for at least 10 minutes at a time. During the last 7 days, on 
how many days did you do moderate physical activities 
like carrying light loads, bicycling at a regular pace, or doubles 
tennis? Do not include walking. 
…………days per week None 
(Skip to 
question 3a) 
2b: How much time in total did you usually spend on one of 
those days doing moderate physical activities? ………………hours 
………………minutes 
3a: During the last 7 days, on how many days did you walk for 
at least 10 minutes at a time? This includes walking at work and 
at home, walking to travel from place to place, and any other 
walking that you did solely for recreation, sport, exercise or 
leisure. 
…………days per week None 
(Skip to 
question 4)
3b: How much time in total did you usually 
spend walking on one of those days? ………………hours 
………………minutes 
4: The last question is about the time you spent sitting on 
weekdays while at work, at home, while doing course work and 
during leisure time. This includes time spent sitting at a desk, 
visiting friends, reading traveling on a bus or sitting or lying 
down to watch television.  
During the last 7 days, how much time in total did you usually 
spend sitting on a week day?
………………hours 
………………minutes 
11 
SF-12 
This survey asks for your views about your health. This information will help you keep 
track of how you feel and how well you are able to do your usual activities. 
Answer every question by selecting the answer as indicated. If you are unsure about 
how to answer a question, please give the best answer you can.  
1. In general, would you say your health is: 
 Excellent 
 Very good 
 Good 
 Fair 
 Poor 
2-3. The following questions are about activities you might do during a typical day. 
Does your health now limit you in these activities? If so, how much? 
Activity Yes, limited a lot Yes, limited a 
little 
No, not limited at 
all 
2. Moderate activities, such 
as moving a table, pushing a 
vacuum cleaner, bowling, or 
playing golf 
   
3. Climbing several flights 
of stairs 
   
4- 5. During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of your physical health? 
4. Accomplished less than you would like  Yes     No
5. Were limited in the kind of work or other activities   Yes    No 
6-7. During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of any emotional problems (such as feeling depresses 
or anxious)?
6. Accomplished less than you would like?  Yes    No
7. Did work or other activities less carefully than usual?  Yes    No
8. During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)? 
 Not at all 
 A little bit 
 Moderately 
 Quite a bit  
 Extremely 
12 
9-11. These questions are about how you feel and how things have been with you during the 
past 4 weeks. For each question, please give the one answer that comes close to the way you 
have been feeling. How much of the time during the past 4 weeks..
All of the 
time 
Most of the 
time 
A good bit 
of the time 
Some of 
the time 
A little 
of the 
time 
None of 
the time 
9. Have you 
felt calm and 
peaceful? 
      
10. Did you 
have a lot of 
energy? 
      
11. Have you 
felt 
downhearted 
and blue?  
      
12. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting friends, relatives, etc.)? 
͔ All of the time 
͔ Most of the time 
͔ Some of the time 
͔ A little of the time 
͔ None of the time  
13 
Modified Health Assessment Questionnaire – MHAQ. 
Please check the response that best describes your usual abilities OVER THE COURSE OF 
THE LAST WEEK.
Are you able to: Without 
any 
difficulty 
With some 
difficulty 
With much 
difficulty 
Unable 
to do 
Dress yourself, including tying 
shoelaces 
and doing buttons? 
    
Get in and out of bed?     
Lift a full cup or glass to your 
mouth? 
    
Walk outdoors on flat ground?     
Wash and dry your entire body?     
Bend down to pick up clothing 
from the floor? 
    
Turn regular faucets on and off?     
Get in and out of a bus, car, train, 
or airplane? 
    
14 
The self- esteem scale. 
Strongly 
agree 
Agree No 
disagreement/ 
agreement 
Disagree Strongly 
disagree 
I feel that I have a number of good 
qualities 
     
All in all, I am inclined to feel that I am a 
failure 
     
I am able to do things as well as most other 
people 
     
I take a positive attitude toward myself      
I certainly feel useless at times      
I wish I could have more respect for myself      
I feel that I am a person of worth, at least 
on an equal plane with others 
     
I feel I do not have much to be proud of      
On the whole, I am satisfied with myself      
At times I think I am no good at all      
Mastery Scale  
Strongly 
agree 
Agree No 
disagreement/ 
agreement 
Disagree Strongly 
disagree 
I have little control about things that 
happen to me 
     
What will happen in the future 
considerably depends on myself 
     
Some of my problems I can't seem to solve 
at all 
     
There is not much that I can do to change 
important things in my life 
     
I often feel helpless dealing with the 
problems of life 
     
Sometimes I feel like a play ball of life      
I can do almost everything, if I want to      
To what extent do you agree with the following statements about your relationship with your 
training and your relationship to activities like the Birkebeiner cross country ski race? 
Strongly 
disagree 
Strongly 
agree 
The sport means a lot to my quality of life     
Good sports performance means a lot to 
me 
    
Participation in the Birkebeiner cross 
country ski race is a motivation for 
practicing systematic 
    
1 How do you in general consider your own 
health to be?
F Very good
F Good
F Neither good nor bad
F Bad 
F Very bad
2 How is your health compared to others in your age?
F Much better
F A little better
F About the same
F A little worse
F Much worse
3 Do you have, or have you had? Yes  No
Age first
time
Heart attack .............................................. FF
Angina pectoris ........................................ FF
Stroke/brain hemorrhage..................... FF
Atrial fibrillation ..................................... FF
High blood pressure ............................... FF
Osteoporosis .............................................. FF
Asthma ......................................................... FF
Chronic bronchitis/Emphysyma/COPD .... FF
Diabetes mellitus .................................... FF
Psychological problems (for which you 
have sought help )
FF
Low metabolism........................................ FF
Kidney disease, FF
Migraine .......................................................FF
4 Do you have persistent or constantly recurring
pain that has lasted for 3 months or more?
F Yes F No
5 How often have you suffered from sleeplessness during 
 the last 12 months? 
F Never, or just a few times
F 1-3 times a month
F Approximately once a week
F More that once a week
6 Below you find a list of different situations.  
Have you experienced some of them in the last week
(including today)? (Tick once for each complaint)
No
complaint
Little Pretty 
much
Very 
much
Sudden fear without reason F F F F
You felt afraid or 
worried ........................................ F F F F
Faintness or dizziness ........... F F F F
You felt tense or
upset .............................................F F F F
Easily blamed yourself .......... F F F F
Sleeping problems .................. F F F F
Depressed, sad ......................... F F F F
You felt useless,
worthless .....................................F F F F
Feeling that life is a struggle F F F F
Feeling of hopelessness with 
regard to the future .............. F F F F
7 Have you during the past year visited:
If YES; how many times?
Yes No   No. of times
General practitioner (GP) .................... F F
Psychiatrist/psychologist ......................F F
Medical specialist outside hospital 
(other than general practitioner/psychiatrist)F F
Physiotherapist ..........................................F F
Chiropractor ...............................................F F
Alternative medical practitioner
(homeopath, acupuncturist, foot zone therapist, 
herbal medical practitioner, laying on hands 
practitioner,  healer, clairvoyant, etc.)
F F
Dentist/dental service ........................... F F
The form will be read electronically. Please use a blue or black pen 
You can not use comas, use upper-case letters.
2007 – 2008 Confidential
9 Have you undergone any surgery during the last 3 years?
F Yes F No
8 Have you during the last 12 months been to  
a hospital? Yes  No  No. of times
Admitted to a hospital ...........................F F
Had consultation in a hospital without admission;
At psychiatric out-patient clinic F F
At another out-patient clinic ..... F F
USE OF HEALTH SERVICES
HEALTH AND DISEASES
not including urinary 
tract  infection (UTI)
complaint
19 What is your main occupation/activity? (Tick one)
F Full time work F Housekeeping
F Part time work F Retired/benefit recipient
F Unemployed F Student/military service
10 Do you take, or have you taken some of the  
following medications? (Tick once for each line)
Never 
used Now Earlier
Age 
first 
time
Drugs for high blood pressure F F F
Lipid lowering drugs .................F F F
Drugs for heart disease .......... F F F
Diuretics ........................................F F F
Medications for 
osteoporosis .................................F F F
Insulin ............................................ F F F
Tablets for diabetes .................F F F
Drugs for metabolism
Thyroxine/levaxin .................... F F F
11 How often have you during the last 4 weeks used
the following medications?(Tick once for each line)
Not used 
the last 
4 weeks
Less than 
every 
week 
Every 
week, but 
not daily Daily
Painkillers on 
prescription ......... F F F F
Painkillers non- 
prescription .......... F F F F
Sleeping pills ........F F F F
Tranquillizers  ..... F F F F
Antidepressants  ..F F F F
12 State the names of all medications -both those 
on prescription and non-prescription drugs- you 
have used regularly during the last 4 weeks.  
Do not include vitamins, minerals, herbs, natural  
remedies, other nutritional supplements, etc. 
When attending the survey centre you will be  
asked whether you have used antibiotics or  
painkillers the last 24 hours. If you have, you  
will be asked to provide the name of the drug,  
strength, dose and time of use. 
13 Who do you live with? (Tick for each question 
and give the number)
Yes No Number
Spouse/cohabitant ................................F F
Other persons older than 18 years.. F F
Persons younger than 18 years ........ F F
14 Tick for relatives who have or have had
Parents Children Siblings
Myocardial infarction ..................... F F F
Myocardial infarction before 60 years F F F
Angina pectoris .................................F F F
Stroke/brain haemorrhage .......... F F F
Osteoporosis  ..................................... F F F
Stomach/duodenal ulcer .............. F F F
Asthma ................................................. F F F
Diabetes mellitus .............................F F F
Dementia .............................................F F F
Psychological problems ................. F F F
Drugs/substance abuse ................. F F F
15 Do you have enough friends who can give you 
help when you need it?  
F Yes F No
16
Do you have enough friends whom you can talk 
confidentially with? 
F Yes F No
17 How often do you normally take part in 
organised gatherings, e.g. sports clubs, political 
meetings, religious or other associations? 
F Never, or just a few times a year
F 1-2 times a month
F Approximately once a week
F More than once a week
WORK, SOCIAL SECURITY AND INCOME 
18 What is the highest level of education you have 
completed? (Tick one)
F Primary, 1-2 years secondary school
F Vocational school
F High secondary school (A-level)
F College/university less than 4 years
F College/university 4 years or more
FAMILY AND FRIENDS
If the space is not enough for all medications, use an additional 
paper of your own.
USE OF MEDICINE
25 How often do you exercise?  (With exercise we mean
for example walking, skiing, swimming or 
training/sports) 
F Never
F Less than once a week
F Once a week
F 2-3 times a week
F Approximately every day
36 How many years in all have you smoked daily? 
Number of 
years
35 How old were you when you began smoking daily?
Number of 
years
22 Do you work outdoors at least 25% of the time, or  
in cold buildings (e.g. storehouse/industry  
buildings)?
F Yes F No
23 If you have paid or unpaid work, which statement  
describes your work best?
F Mostly sedentary work
(e.g. office work, mounting)
F Work that requires a lot of walking
(e.g. shop assistant, light industrial work, teaching)
F Work that requires a lot of walking and lifting
(e.g. postman, nursing, construction)
F Heavy manual labour
24
F Reading, watching TV, or other sedentary 
activity.
F Walking, cycling, or other forms of exercise
at least 4 hours a week (here including walking or  
cycling to place of work, Sunday-walking, etc.)
F Participation in recreational sports, heavy gardening, 
etc. (note:duration of activity at least 4 hours a week)
F Participation in hard training or sports 
competitions, regularly several times a week.
26 How hard do you exercise on average?
F Easy- do not become short-winded or sweaty
F You become short-winded and sweaty
F Hard- you become exhausted
29 How many units of alcohol(a beer, a glass of wine or 
a drink) do you usually drink when you drink alcohol?
F 1-2 F 5-6 F 10 or more
F 3-4 F 7-9
32 Do you/did you smoke daily? 
F Yes, 
now
F Yes, 
previously
F Never
27 For how long time do you exercise every time on average?
F Less than 15 minutes F 30-60 minutes
F 15-29 minutes F More than 1 hour
30 How often do you drink 6 units of alcohol or more  
in one occasion?
F Never
F Less frequently than monthly
F Monthly
F Weekly
F Daily or almost daily
28 How often do you drink alcohol?
F Never
F Monthly or more infrequently
F 2-4 times a month
F 2-3 times a week
F 4 or more times a week
21 What was the households total taxable income last
 year? Include income from work, social benefits
and similar
F Less than 125 000 NOK F 401 000-550 000 NOK
F 125 000-200 000 NOK F 551 000-700 000 NOK
F 201 000-300 000 NOK F 701 000 -850 000 NOK 
F 301 000-400 000 NOK F More than 850 000 NOK
34 If you currently smoke, or have smoked before: 
How many cigarettes do you or did you usually 
smoke per day?
Number of 
cigarettes 
33 If you previously smoked daily, how long is it 
since you stopped?
Number of 
years
31 Do you smoke sometimes, but not daily?
F Yes F No
20 Do you receive any of the following benefits?
F
F
F
F Full disability pension
F Partial disability pension
F Unemployment benefits
F Transition benefit for single parents
F Social welfare benefits
37 Do you use or have you used snuff or chewing tobacco?
F No, never F Yes, sometimes
F Yes, previously F Yes, daily
PHYSICAL ACTIVITY
ALCOHOL AND TOBACCO
Old-age, early retirement or survivor pension
Sickness benefit (are in a sick leave)
Rehabilitation benefit
Describe your exercise and physical exertion in 
leisure time. If you activity varies much, for 
example between summer and winter, then give 
an average. The question refers only to the last 
year. (Tick the one that fits best)
48 If you have given birth, fill in for each child: 
 birth year, birth weight and months of  
breastfeeding (Fill in the best you can)
Child Birth year Birth weight in grams
Months of  
breastfeeding
1
2
3
4
5
6
39 How many units of fruits or vegetables do you eat
on average per day? (units means for example
a fruit, a cup of juice, potatoes, vegetables)
Number of units
38 Do you usually eat breakfast every day?
F
40 How many times per week do you eat hot dinner? 
Number
42 How much do you normally drink the following?  
(Tick once for each line)
Rarely/ 
never
1-6 
glasses 
/week
Milk, curdled milk,
yoghurt ....................... F F F F F
Juice ............................F F F F F
Soft drinks
with sugar ................. F F F F F
44 How often do you usually eat cod liver and roe? 
(i.e. “mølje”)
F Rarely/never F 1-3 times/yearF 4-6 times/year
F 7-12 times/year F More than 12 times/year
Yes F No
DIET
2-3  
times/ 
mth
0-1  
times/
mth 
1-3  
times/  
week
4-6  
times/ 
week
1-2  
times/ 
day
1 
glass 
/day
2-3 
glasses 
/day
4 or more 
glasses 
/day
Do you currently use any prescribed drug  
influencing the menstruation? 
45 Do you use the following supplements? 
Daily  Sometimes  No
Cod liver oil or fish oil capsules ......... F F F
Omega 3 capsules (fish oil, seal oil) ........F F F
Vitamins and/or mineral supplementsF F F
47 How many children have you given birth to?
Number
49 During pregnancy, have you had high blood  
pressure?  
F Yes F No
52 If yes, which pregnancy?
F The first F Second or later
53 Were any of your children delivered prematurely  
(a month or more before the due date) because  
of preeclampsia?
F Yes F No
55 How old were you when you started  
menstruating? 
Age
51 During pregnancy, have you had proteinuria?  
F Yes F No
50 If yes, which pregnancy?
F The first F Second or later
54 If yes, which child?
1st child 2nd child 3rd child 4th child 5th child 6th child
F F F F F F
43 How many cups of coffee and tea do you drink 
daily? (Put 0 for the types you do not drink daily)
Number of cups
Filtered coffee ...............................................
Boiled coffee (coarsely ground coffee for brewing)
Other types of coffee ..................................
Tea ......................................................................
56
Oral contraceptives, hormonal 
IUD or similar ........................................... F Yes F No
Hormone treatment for  
menopausal problems ........................... F Yes F No
46 Are you currently pregnant? 
F Yes F No F Uncertain
When attending the survey centre you will get a  
questionnaire about menstruation and possible use  
of hormones. Write down on a paper the names of  
all the hormones you have used and bring the paper  
with you. You will also be asked whether your  
menstruation have ceased and possibly when and  
why. 
 
41 How often do you usually eat these products? 
(Tick once for each line)
Potatoes .............................. F F F F F
Pasta/rice .......................... F F F F F
Meat (not processed) ............F F F F F
Processed meat
(sausages/meatloaf/meatballs)F F F F F
Fruits, vegetables, berriesF F F F F
Lean fish ............................. F F F F F
Fat fish  ...............................F F F F F
(e.g. salmon, trout, mackerel, herring,  
halibut, redfish)
QUESTONS FOR WOMEN
Birkebeiner Atrial Fibrillation Study 
This form shall be read by a machine. 
It is therefore important that you: 
x Use a blue or black pen 
x Make a cross like this   ,  and not like this 
x Write numbers in the following manner: 
0 1 2 3 4 5 6 7 8 9 
 
ABOUT YOU 
1. Gender             Female           Male 
2. Age      years 
3. Height    cm 
4. Weight   kg 
5. Who do you live together with? 
Live alone  Spouse/partner Other people 18 years of age and older  People under 18 years of age 
HEALTH 
6. How is your health currently? 
Poor    Fair   Good   Excellent 
7. Do you suffer from or have you ever suffered from the following illnesses? 
(Insert a cross and age when first occurred) 
 
 Yes No Age when 
first occurred 
Confirmed by 
doctor 
Yes          No 
Myocardial infarct      
Angina pectoris      
Hyperthyroidism      
Diabetes      
Operated heart valve      
Heart bypass operation      
High blood pressure      
High cholesterol      
Stroke      
Asthma      
 
8. If you have a heart disease, how does it impact on your ability to function? 
No restrictions. Normal physical activity causes no unusual fatigue, shortness of breath or 
chest pains. 
 
Slight restriction on physical activity, however unaffected when resting. Normal physical 
activity causes fatigue, shortness of breath or chest pains. 
 
Significant restrictions on physical activity. Even minor physical exertion causes fatigue, 
shortness of breath or chest pains. 
 
Impossible to perform any type of physical activity. In periods, also shortness of breath or 
chest pains when resting. 
 
9. Do you use or have you used (insert cross) 
 Yes, now Previously, but 
no longer 
Never 
Blood pressure-lowering medicines    
Cholesterol-reducing medicines    
Inhalation medication against asthma or 
chronic obstructive pulmonary disease 
(COPD) 
   
 
10. Have you had continual muscle or skeletal pains for at least 3 months?  Yes    No 
11. Have you used anti-inflammatory medicines over an extended period at least once in your 
life (Voltaren, Diclofenac, Brexidol, Naproxen, Naprosyn, Vioxx, Celebra, Ibux, Ibuprofen or 
similar)?    Yes    No 
 
At least 2 consecutive weeks 
At least 4 consecutive weeks 
At least 8 consecutive weeks 
At least 3 consecutive months 
At least 6 consecutive months 
 
TOBACCO 
12. Do you smoke daily or have you previously smoked daily (cigarettes)? 
Yes, now       Yes, previously            Never 
13. If yes, how many cigarettes do/did you normally smoke per day?    Number: 
14. For how many years in total have you smoked/did you smoke daily?   Number: 
15. Do you use or have you used snus? 
Yes, now       Yes, previously            Never 
16. For how many years in total have you used/did you use snuff?   Number: 
ALCOHOL 
17. Are you a complete teetotaller? 
Yes, now   Yes, have always been teetotal   No 
 
If you have always been teetotal, go directly to question 22. 
 
18. Approximately how often have you consumed alcohol in the past year? 
(Light beer and alcohol-free beer are not included) 
Insert a cross in the appropriate box. 
 
4-7 times 
per week 
2-3 times 
per week 
Approx. 
once per 
week 
2-3 times 
per 
month 
About 
once per 
month 
A few 
times in 
the past 
year 
Not in 
the past 
year 
Never 
19. How many glasses of the following drinks do you normally consume in a 2 week period? 
Beer   Number 
Wine  Number 
Spirits Number 
20. When you have consumed alcohol, how many glasses and/or drinks have you normally had?  
Number 
21. Approximately how many times during the past year have you drunk as much as at least 5 
glasses/drinks during a 24 hour period?     Number 
STRESS 
22. Insert a cross for the alternative that best describes your situation (only one cross for the “At 
home” and one cross for the “At work” column). By stress we mean that one feels tense, 
nervous, anxious or has problems with sleeping due to circumstances at home or at work. 
 
 At home At work 
Have never experienced stress   
Have sometimes experienced stress   
Have experienced stress during the past 5 years   
Have experienced several periods of stress during the 
past 5 years 
  
Have experienced persistent stress in the past year   
Have experienced persistent stress in the past 5 years   
 
PHYSICAL ACTIVITY AND EXERCISE 
23. State the movement and physical activity you engage in during your leisure time. If the level 
of activity varies significantly, e.g. between summer and winter, use an average. The 
question applies to the past 12 months. 
(Insert a cross in the most appropriate box) 
 
Reading, sitting still or other sedentary activities 
Walking, cycling or other manner of movement 2-4 hours per week 
Walking, cycling or other manner of movement at least 4 hours per week 
Recreational exercise, heavier garden work or the like. (Note that the activity must be for at 
least 4 hours per week). 
Hard exercise or competitive sport on a regular basis and several times per week. 
24. Have you at any time in your life engaged in regular endurance exercise (exercise sessions 
for a minimum of 30 minutes at least 3 times per week with the goal of better endurance)? 
Yes   No 
If yes, proceed to question 25 
If no, go directly to question 34 
25. How old were you when you started regular endurance exercise?    Age: 
26. How many years in total have you engaged in regular endurance exercise with the goal of 
better endurance? 
Less than 
5 years 
5-9 years 10-19 
years 
20-29 
years 
30-39 
years 
40-49 
years 
50-59 
years 
More 
than 60 
years 
        
 
27. Approximately how many times per week on average have you engaged in endurance 
exercise during these years? 
(Insert only one cross per row) Hours per week 
Age period < 2 hours 2-3 hours 4-5 hours 6-7 hours More than 7 
hours 
11-15      
16-20      
21-30      
31-40      
41-50      
51-60      
Over 60      
 
28. What type of endurance exercise have you mostly been engaged in? 
Mostly sessions with low intensity (heart rate <75% of max heart rate or able to conduct a 
conversation) 
Mostly sessions with high intensity (heart rate >75% of max heart rate, e.g. interval training) 
About half of the sessions at low intensity and half at high intensity 
 
29. On average, how many times per week have you exercised at high intensity in the past year? 
30. On average, how many times per week have you exercised at low intensity in the past year? 
31. Do you still engage in regular endurance exercise? 
Yes      No 
32. How many times in the course of your life have you engaged in endurance exercise even 
though you had a noticeable cold, an infection or fever? 
Never    Less than 5 times    5-15 times    More than 15 times 
33. How many times in the course of your life have you competed in endurance sport even 
though you had a noticeable cold, an infection or fever? 
Never    Once    2-3 times    4-5 times          More than 5 times 
 
PARTICIPATION IN THE BIRKEBEINER RACE 
34. Have you competed in the Birkebeiner ski race? 
Yes   No 
If yes, proceed to question 35 
If no, go directly to question 41 
35. How many times have you competed in the Birkebeiner race?   Number: 
36. How many times have you achieved the Birkebeiner Medal (Merket)?       Number: 
37. How old were you the first time you competed? 
IF YOU HAVE STOPPED COMPETING IN THE BIRKEBEINER RACE: 
38: How old were you when you competed for the last time?    Age: 
39: What was the most important reason for you no longer competing? 
Atrial fibrillation 
Heart attack 
Other illness 
No longer motivated 
Had no desire due to being in poorer physical condition than previously 
Other 
40. Do you still compete in sporting competitions other than the Birkebeiner race?  Yes   No 
ATRIAL FIBRILLATION 
41. Have you noticed instances of sudden changes in pulse or heart rhythm in the past year?  
Yes   No 
42: Do you believe yourself that you have or have had atrial fibrillation (heart fibrillation)? 
Yes    No  Don’t know 
43. If yes, have you been diagnosed as suffering from atrial fibrillation by a doctor? 
Yes    No  Don’t know 
44. If yes, where? 
Regular doctor     Hospital doctor 
Name of the hospital……………………………………………………………………………………………………. 
45. Do you suffer from persistent or paroxysmal atrial fibrillation? 
(a) Have atrial fibrillations the entire time (b) Have/have had incidences that end by themselves 
or with tablet treatment. 
(c) Have/have had incidences that are only alleviated by intravenous treatment or electric shock. 
 
46. How often on average do you experience such incidences? 
2 or more times per week  About once per week  1-3 times per month Less than once per month 
 
47. The incidences occur most often: 
During exercise/physical exertion 
After exercise/physical exertion 
At night 
In connection with stress 
During or after consuming alcohol 
After large meals 
In connection with infections/fever 
Without any clear connection with any of the above alternatives 
48. When did you experience your first incidence of atrial fibrillations? 
Month and year (e.g. 03.76) 
49. When were you diagnosed as suffering from atrial fibrillations? 
Month and year (e.g. 03.76) 
50. Do you use the following medicines as a result of atrial fibrillations? 
 Use Have used 
Beta blockers daily (e.g. Zelo-Zok, Metoprolol, Sotalol, 
Sotacor, Emconcor) 
  
Beta blockers in the event of an attack   
Calcium blocks daily (e.g. Isoptin, Verapamil, Veracard)   
Calcium blockers in the event of an attack   
Cordarone daily   
Cordarone in the event of an attack   
Tambocor/Flecainide daily   
Tambocor/Flecainide in the event of an attack   
Digitoxin/Digoxin/Lanoxin   
Albyl-E/Magnyl-E/Acetylsalicylic acid   
Multaq/Dronedarone   
Marevan   
Dabigatran/Pradaxa   
 
 
51. Does anyone in your immediate family suffer from atrial fibrillation? (Insert cross) 
Mother   Father   Sibling   Child 
52. How many times during your life (until you began to suffer from atrial fibrillation) have you used 
anti-inflammatory medicines more than once per day for at least a week at a time (Voltaren, 
Diclofenac, Brexidol, Naproxen, Naprosyn, Vioxx, Celebra, Ibux, Ibuprofen or similar)? 
Never    Less than 5 times    5-15 times    More than 15 times  Don’t know 
 
EDUCATION AND INCOME 
53. What is the highest level of education you completed? 
 9 years or less of elementary school 
High school graduate/upper secondary school 
Less than 4 years’ college/university education 
4 Years or more of college/university education 
 
54. How many years of education have you completed? 
Include all the years you went to school or studied.           Number: 
 
54. What was your total gross income in the past year? 
(Pensioners: What was your combined gross income BEFORE YOU RETIRED)? 
 
NOK 
 

OM DEG
HELSE
TOBAKK
1. Kjønn   Kvinne         Mann
6. Hvordan er helsen din nå?
12. Røyker du daglig eller har du tidligere
røyket daglig (sigaretter)?
13. Hvis ja, hvor mange sigaretter røyker
eller røykte du vanligvis daglig?
11. Har du brukt betennelsedempende medisiner over en
10. Har du i minst 3 måneder sammenhengende hatt
muskel- eller skjelettsmerter?
7. Har du eller har du hatt følgende sykdommer:
(sett kryss og alder første gang.)
9. Bruker du eller har du brukt: (sett kryss)
8. Hvis du har hjertesykdom, hvordan virker dette på ditt
funksjonsnivå?
2. Alder     år
3. Høyde            cm
4. Vekt            kg
5. Hvem bor du sammen med?
Ingen
Ja, nå
Antall:
Ja, tidligere Aldri
Ja
Ja, nå
Ja
Hjerteinfarkt
Angina pectoris
Høyt stoffskifte/hypertyreose
Sukkersyke/diabetes
Operasjon av hjerteklaff
Bypass-operasjon i hjertet
Høyt blodtrykk
Høyt kolesterol
Hjerneslag
Astma
Blodtrykkssenkende medisiner
Kolesterolsenkende medisiner
Inhalasjonsmedisin mot 
astma eller kols
Ingen begrensninger. Vanlig fysisk aktivitet gir ingen 
uvanlig tretthet, tungpust eller brystsmerter.
Lett begrensning av fysisk aktivitet, men ubesværet i 
hvile. Vanlig fysisk aktivitet gir tretthet, tungpust eller 
brystsmerter.
Betydelige begrensninger i fysisk aktivitet. 
Selv små fysiske anstrengelser gir tretthet, tungpust 
eller brystsmerter.
Umulig å utføre noen som helst fysisk anstrengelse. 
Periodevis også tungpust eller brystsmerter i hvile.
Minst 2 uker sammenhengende
Minst 4 uker sammenhengende
Minst 8 uker sammenhengende
Minst 3 måneder sammenhengende
Minst 6 måneder sammenhengende
Ektefelle/
Samboer
Dårlig Ikke helt god
Nei
Før, men 
ikke nå
Alder
første
gang
Bekreftet
av lege
Aldri
Nei
Andre personer
18 år og eldre
God
Personer 
under 18 år
Svært god
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14. Hvor mange år har du til sammen
røyket daglig?
16. Hvor mange år har du til sammen
brukt snus?
Antall:
Antall:
15. Bruker du eller har du brukt snus?
Ja, nå Ja, tidligere Aldri
Ja
lengre periode minst en gang i livet (Voltaren, Diclofenac, 
Brexidol, Naproxen, Naprosyn, Vioxx, Celebra, Ibux, 
Ibuprofen el. lignende)? Ja Nei
Nei
10 2 3 4 5 6 7 8 9
22. Sett kryss for det alternativet som passer best for din
situasjon (kun ett kryss for kolonnen “Hjemme” og ett 
kryss for kolonnen “På jobb”.) Med stress mener vi at 
man kjenner seg spent, nervøs, engstelig eller har prob-
lemer med søvnen på grunn av forhold hjemme eller på 
jobb.
18. Omtrent hvor ofte har du i løpet av det siste året
drukket alkohol?
(Lettøl og alkoholfritt øl regnes ikke med).
Sett kryss i passende rute.
4-7
ganger
i uka
2-3
ganger
i uka
Ca.
1 gang
i uka
2-3
ganger
pr. mnd.
Omtrent
1 gang
pr. mnd.
Noen få
ganger
siste år
Ikke 
siste år Aldri
ALKOHOL
STRESS
17. Er du total avholdsmann/-kvinne?
19. Hvor mange glass drikker du vanligvis i
løpet av 2 uker av:
Øl       Antall:
Vin       Antall:
Brennevin       Antall:
20. Når du har drukket alkohol,
hvor mange glass/og eller drinker
har du vanligvis drukket?
21. Omtrent hvor mange ganger i løpet
av det siste året har du drukket så mye som
minst 5 glass/drinker i løpet av ett døgn?
Antall:
Antall:
Har aldri opplevd stress
Har opplevd stress noen ganger
Har opplevd stress i løpet av de 
5 siste årene
Har opplevd ﬂere stressperioder de
5 siste årene
Har opplevd vedvarende stress det 
siste året
Har opplevd vedvarende stress de 
siste 5 årene
Hjemme
På 
jobb
23. Angi bevegelse og kroppslig anstrengelse i din fritid.
Hvis aktiviteten varierer mye, for eksempel mellom 
sommer/vinter, så ta et gjennomsnitt. Spørsmålet gjelder 
bare de 12 siste månedene. 
      (Sett kryss i den ruten som passer best)
24. Har du noen gang i livet drevet regelmessig
utholdenhetstrening (treningsøkter med varighet
 på minst 30 minutter minst 3 ganger i uken 
med mål om å bedre utholdenhet)?
Hvis ja, fortsett med spørsmål 25
Hvis nei, gå direkte til spørsmål 34
Hvis du alltid har vært avholdsmann/-kvinne 
gå direkte til spørsmål 22.
FYSISK AKTiVITET OG TRENING
Leser, sitter stille eller annen stillesittende 
beskjeftigelse
Spaserer, sykler eller beveger deg på annen
måte 2–4 timer i uken
Spaserer, sykler eller beveger deg på annen 
måte minst 4 timer i uken
Driver mosjonsidrett, tyngre hagearbeid eller 
lignende (Merk at aktiviteten skal vare minst 
4 timer i uken)
Trener hardt eller driver konkurranseidrett
regelmessig og ﬂere ganger i uken 
Ja Nei
25. Hvor gammel var du da du begynte med
regelmessig utholdenhetstrening? Alder:
26. Hvor mange år tilsammen har du drevet regelmessig
utholdningstrening ﬂere ganger i uken med mål om å
bedre utholdenheten?
Under
5 år
5-9
år
10-19
år
20-29
år
30-39
år
40-49
år
50-59
år
Mer 
enn
60 år
Ja, nå
Ja, har alltid
vært avholds Nei
11–15 år
16–20 år
21–30 år
31–40 år
41–50 år
51–60 år
Over 60 år
6-7t< 2tAldersperiode
      årene?
(Sett kun ett kryss i hver rad) Timer pr. uke
2-3t 4-5t
mer enn 
7 timer
27. Omtrent hvor mange timer i uka har du gjennom-
      snittlig drevet utholdenhetstrening i løpet av disse
39. Hva var den viktigste årsaken til at du sluttet å delta?
40. Deltar du fortsatt i andre mosjonskonkurranser enn
Birkebeinerrennet?
ATRIEFLIMMER
HVIS DU HAR SLUTTET Å DELTA I 
BIRKEBEINERRENNET:
Atrieﬂimmer
Hjerteinfarkt
Annen sykdom
Ikke motivert lenger
Orket ikke på grunn av dårligere fysisk form enn før
Annet
31.
30. I snitt hvor mange ganger i uken har du
trent med lav intensitet det siste året?
29. I snitt hvor mange ganger i uken har du
trent med høy intensitet det siste året?
Driver du fortsatt med regelmessig
utholdenhetstrening?
Ja Nei
32. Hvor mange ganger i løpet av livet har du trent
utholdenhetstrening selv om du har vært merkbart 
forkjølet, hatt en infeksjon eller hatt feber?
33. Hvor mange ganger i løpet av livet har du deltatt i
konkurranse i utholdenhetsidrett selv om du har vært 
merkbart forkjølet, hatt en infeksjon eller feber?
Aldri
Mindre 
enn 5 
ganger
5-15 
ganger
2-3 
Aldri En gang ganger
mer enn 
15 ganger
4-5
ganger
Mer enn 
5 ganger
28. Hva slags type utholdenhetstrening har du
drevet mest med?
Flest økter med lav intensitet (puls <75% av 
maks puls, eller i stand til å føre en samtale)
Flest økter med høy intensitet (puls >75% av 
maks puls, for eksempel intervalltrening.)
Omtrent halvparten av øktene med lav inten-
sitet og halvparten med høy intensitet
38. Hvor gammel var du da du
deltok siste gang? Alder:
42. Mener du selv at du har eller har hatt atrieﬂimmer
(forkammerﬂimmer/hjerteﬂimmer)?
41. Har du merket anfall med plutselig endring i pulsen
eller hjerterytmen siste året?
43. Hvis ja, har du fått stilt diagnosen atrieﬂimmer
hos lege?
Hvis nei gå til spørsmål 53
44.
      Navn på sykehus...............................................................
Ja
Ja
Ja
Ja
Hvis ja, hvor?
fastlege
Nei
Nei
Nei
Nei
lege på sykehus,
Vet ikke
Vet ikke
34. Har du deltatt i Birkebeinerrennet på ski?
Hvis ja, fortsett med spørsmål 35
Hvis nei, gå direkte til spørsmål 41
DELTAKELSE I BIRKEBEINERRENNET
35. Hvor mange ganger har du gått
Birkebeinerrennet?
36. Hvor mange ganger har du gått
til Merket?
37. Hvor gammel var du første gang
du deltok?
Antall:
Antall:
Alder:
Ja Nei
45. Har du permanent eller anfallsvis atrieﬂimmer?
a) har atrieﬂimmer hele tiden (permanent)
b) har/har hatt anfall som går over av seg selv
eller med tablettbehandling
c) har/har hatt anfall som kun går over med
intravenøs behandling eller elektrosjokk
UTDANNING OG INNTEKT
47. Anfallene op er oftest:
50. Bruker du følgende medikamenter på grunn
atrieﬂimmer? (Sett kryss)
under trening/fysiske anstrengelser
etter trening/fysiske anstrengelser
om natten
i forbindelse med stress
under eller etter inntak av alkohol
etter større måltider
i forbindelse med infeksjoner/feber
uten tydelig sammenheng med noen 
av alternativene ovenfor
Betablokker daglig (F.eks Zelo-Zok, 
Metoprolol, Sotalol, Sotacor, Emconcor)
Betablokker ved anfall
Kalsiumblokker daglig (F.eks Isoptin, 
Verapamil, Veracard)
Kalsiumblokker ved anfall
Cordarone daglig
Cordarone ved anfall
Tambocor/Flecainid daglig
Tambocor/Flecainid ved anfall
Digitoxin/Digoxin/Lanoxin
Albyl-E/Magnyl-E/Acetylsalisylsyre
Multaq/Dronedarone
Marevan
Dabigatran/Pradaxa
Bruker
Har 
brukt
51. Har noen av dine e familiemedlemmer
atrieﬂimmer? (Sett kryss)
52. Hvor mange ganger i løpet av livet (fram til du 
atrieﬂimmer) har du brukt betennelsesdempende
medisiner ﬂere ganger daglig i minst en uke av gangen
(Voltaren, Diclofenac, Brexidol, Naproxen, Naprosyn,
Vioxx, Celebra, Ibux, Ibuprofen el. lignende)?
46. Hvor ofte har du i snitt anfa
8. Når hadde du ditt første anf4
 med atrieﬂimmer?
49. Når ble diagno
 atrieﬂimmer stilt?
mor
aldri
2 eller 
ﬂere
ganger 
pr. uke
Mnd. og år (f. eks. 03.76)
Mnd. og år (f. eks. 03.76)
.
.
1-3 
ganger pr. 
mnd. far
mindre enn 
5 ganger
søsken barn
5-15 
ganger
mer enn 15 
ganger
Vet
ikke
omtrent 
1 gang 
pr. uke
Sjeldnere 
enn 1 gang 
pr. mnd
3. Hvilken utdanning er den høyeste du har fullfø5
9 år grunnskole eller mindre
artium/videregående skole
mindre enn 4 år høgskole/universitetsutdanning
4 år eller mer på høgskole/universitet
54. Hvor mange års skolegang har du gjennomfø
Ta med alle år du har gått på skole eller studert.
55. Hva var din samlede brutto inntekt siste 
(Pensjonister: Hva var din samlede brutto inntekt
FØR DU BLE PENSJONIST)?
IKKE SETT KRYSS HER
(fylles ut av mottaker.)
Antall:
Kr.
